Skip to main content
Food Science & Nutrition logoLink to Food Science & Nutrition
. 2025 Oct 7;13(10):e71024. doi: 10.1002/fsn3.71024

Functional Foods Enriched With Bioactive Compounds: Therapeutic Potential and Technological Innovations

Zargull Arshad 1, Shafa Shahid 1, Ammarah Hasnain 1,, Esha Yaseen 1, Mehdi Rahimi 2,3,
PMCID: PMC12501769  PMID: 41063746

ABSTRACT

Functional foods have gained increasing attention for their dual role in providing essential nutrition and promoting health through the presence of bioactive compounds. These compounds, naturally found in a variety of plant and animal sources, include polyphenols, carotenoids, omega‐3 fatty acids, probiotics, prebiotics, alkaloids, and terpenoids. They exhibit a wide range of therapeutic effects, mediated through mechanisms such as antioxidant activity, anti‐inflammatory responses, modulation of gut microbiota, and enzyme inhibition. This review offers a comprehensive classification of these key bioactive compounds, detailing their natural origins with an emphasis on their mechanisms of action. Additionally, it explores their incorporation into diverse functional food matrices, including fortified beverages, dairy products, snack items, and dietary supplements. Modern biotechnological and AI‐driven approaches have revolutionized the precision, efficacy, and characterization of functional food products by enabling high‐throughput screening of bioactive compounds, predictive modeling for formulation, and large‐scale data mining to identify novel ingredient interactions and health correlations. Despite the growing popularity of functional foods, challenges persist in terms of the stability and bioavailability of bioactive compounds, regulatory hurdles, and consumer acceptance. Addressing these issues is critical to ensuring the efficacy and safety of functional food products. The review also highlights future perspectives in the field, emphasizing the need for innovative delivery systems and multidisciplinary research to enhance the bioavailability, functionality, and accessibility of these products. By highlighting the challenges and proposing possible solutions, this review serves as a foundational reference for bridging the gap among researchers, healthcare professionals, and stakeholders.

Keywords: bioactive compounds, biotechnological and AI‐driven approaches, carotenoids, gut microbiome modulation, omega 3‐fatty acids, polyphenols, probiotics and prebiotics


Functional foods enriched with bioactive compounds such as polyphenols, carotenoids, omega‐3 fatty acids, and probiotics provide therapeutic benefits through antioxidant, anti‐inflammatory, and gut‐modulating mechanisms. Advances in biotechnology and AI have improved screening, formulation, and delivery of these compounds in diverse food matrices including dairy, beverages, and supplements. Despite challenges in stability, bioavailability, and regulation, innovative strategies and multidisciplinary research offer promising solutions to enhance efficacy, safety, and consumer acceptance of functional foods.

graphic file with name FSN3-13-e71024-g007.jpg

1. Introduction

Functional foods are dietary compounds that provide health benefits beyond basic nutrition due to the presence of crucial bioactive compounds such as polyphenols, carotenoids, omega‐3 fatty acids, alkaloids, isothiocyanates, plant stanols, sterols, flavonoids, polyols, soy protein, fatty acids, prebiotics, probiotics, phytoestrogens, as well as various minerals and vitamins (Shaikh 2022; Topolska et al. 2021). The concept of functional food originated in Japan during the 1980s, when government agencies began approving foods with verified health benefits (Arshad et al. 2021). The idea of functional foods has its roots in traditional dietary practices and has developed into scientifically formulated products designed to improve overall health and prevent diseases (Vignesh et al. 2024) (Figure 1).

FIGURE 1.

FIGURE 1

Functional food: types, activities, and future challenges.

In contrast to the conventional food that provides basic nutrition, functional foods are enriched with compounds that contribute to specific physiological effects (Table 1). Conventional foods provide essential nutrients required for survival while functional foods are enriched with bioactive ingredients that actively contribute to physiological well‐being (Hasler 2002; Victoria Obayomi et al. 2024).

TABLE 1.

Comparison of conventional vs. functional foods based on formulation, regulation, and health benefits.

Feature Conventional food Functional food References
Primary role Provides essential nutrition Offers health benefits beyond nutrition Frumuzachi et al. (2025)
Formulation Basic nutrients Basic nutrients + bioactive compounds Temple (2022)
Health claims General Specific McClements and Xiao (2014)
Regulation Standard food safety laws Additional oversight for health‐related claims Frumuzachi et al. (2025)
Examples Rice, milk, bread Probiotc yogurt, fortified cereals, omega‐3‐eggs Tafese Awulachew (2024)

Key stages that involve in developing functional food are identification of beneficial compounds, their extraction from natural sources, and their incorporation into food matrices while ensuring stability, bioavailability, and efficacy (Rezagholizade‐shirvan et al. 2024). In addition to the key stages the ultimate step in developing functional food ensures that the food is palatable and acceptable to the consumers and this requires careful consideration of sensory properties, cost and convenience (Jones and Jew 2007; Vlaicu et al. 2023).

According to recent research, the bioactive compounds that are potentially found in food play a significant role in lowering the risk of chronic diseases, promoting gut health, reducing inflammation, boosting immune function, enhancing cognitive abilities, and assisting in weight management (Essa et al. 2023; Rivero‐Pino and Montserrat‐de la Paz 2024). The bioactive compounds, derived from plant‐based, marine, and microbial sources, have demonstrated great potential in addressing prevalent health concerns such as obesity, diabetes, cardiovascular diseases, and neurodegenerative disorders (Ud Din et al. 2023; Vignesh et al. 2024). The growing body of evidence supporting the health benefits of functional foods has led to their incorporation into dietary guidelines and health policies on a global scale (Xavier et al. 2024). The regulatory landscape for functional foods varies regionally, with some countries having established guidelines. Effectiveness relies on scientific validation, quality control, and labeling, requiring collaboration between food scientists, nutritionists, and regulatory agencies (Martirosyan and Alvarado 2023).

Recent meta‐analytic evidence indicates that polyphenols can significantly improve muscle mass in sarcopenic individuals, highlighting their therapeutic potential (Medoro et al. 2024). Omega‐3 fatty acid supplementation (0.8–1.2 g/day) significantly reduces the risk of major cardiovascular events, heart attacks, and cardiovascular death, especially in patients with coronary heart disease according to the meta‐analysis by Shen et al. (2022). Probiotic efficacy has been evaluated through meta‐analyses across conditions like irritable bowel syndrome (IBS), allergic rhinitis, and pediatric atopic dermatitis, offering stronger evidence on their therapeutic and preventive benefits (Farahmandi et al. 2022; Lee et al. 2008).

The development of functional foods encounters several challenges, such as consumer perception, affordability, and the sustainability of sourcing bioactive ingredients. Some consumers are still doubtful about the health benefits associated with functional foods, highlighting the need for public education and clear scientific communication (Baker et al. 2022). Furthermore, it is important to ensure the sustainable production of bioactive compounds while keeping costs manageable to make functional foods accessible to a wide range of populations (Yuan et al. 2024).

In this review, crucial bioactive compounds, their natural origins, and their contribution to the creation of functional foods have been studied. By comprehending the characteristics and mechanisms of these bioactive compounds, researchers and food technologists can develop innovative functional foods that promote health and well‐being. Ongoing progress in food technology and nutrigenomics offers promising opportunities to enhance the effectiveness of functional foods, leading to a healthier future.

2. Key Bioactive Compounds and Their Sources

2.1. Polyphenols as Potent Antioxidants and Disease Modulators

Polyphenols are one of the most prevalent classes of bioactive metabolites in plants, which are important for the human body through their impactful antioxidant, anti‐inflammatory, and antimicrobial activities. Such secondary metabolites are found in a wide range of dietary sources that include fruits, such as berries, apples, and grapes; vegetables, such as spinach, onions, and kale; tea and coffee; and whole grains (Table 1) (Pandey and Rizvi 2009).

Recent studies highlight the role of nanoencapsulation in enhancing the bioavailability and therapeutic effectiveness of polyphenols. Encapsulation techniques improve stability, protect polyphenols from degradation, and enhance absorption in the body, making them more effective in disease prevention and treatment (Ali Redha et al. 2024; Pugazhendhi et al. 2025).

2.2. Carotenoids as Pigments With Nutritional and Therapeutic Potential

Carotenoids are lipophilic pigments widely distributed in nature, known for their dual significance in human health. They can act as both provitamin A carotenoids and preformed vitamin A, playing essential roles in human nutrition and disease prevention. Provitamin carotenoids are found in plant‐based sources like fruits and vegetables such as carrots, tomatoes, bell peppers, and leafy greens (Table 2) (Dumay and Morançais 2016). They contribute to the essential physiological functions including vision, immune response, and cellular growth (Huang et al. 2022). On the contrary, preformed vitamin A is found in foods from animal sources, including dairy products, eggs, fish, and organ meats. They contribute to potential pharmacological properties, particularly antioxidant, anti‐inflammatory, and anticancer activities, although these effects are still under investigation and not yet fully established for clinical trials (NIH 2025).

TABLE 2.

Overview of bioactive compounds, their sources, key health benefits, daily intake threshold vs. pharmacological doses (mg/day).

Bioactive compounds Examples/key functions Major food sources Key health benefits Daily intake threshold (mg/day) Pharmacological doses (mg/day) References
Polyphenols
Flavonoids Quercetin, catechins, anthocyanins, kaempferol Berries, apples, onions, green tea, cocoa, citrus fruits Cardiovascular protection, anti‐inflammatory effects, antioxidant properties, improved blood circulation 300–600 500–1000 Ullah et al. (2020)
Phenolic Acids Caffeic acid, ferulic acid, gallic acid Coffee, whole grains, berries, spices (e.g., cinnamon), olive oil Neuroprotection, antioxidant activity, reduced inflammation, skin health benefits 200–500 100–250 Mihaylova et al. (2024)
Lignans Secoisolarici‐ ‐resinol, matairesinol Flaxseeds, sesame seeds, whole grains, legumes Hormone regulation, cancer prevention, improved gut microbiota, cardiovascular benefits ~1 50–600 Gass and Khan (2013)
Stilbens Resveratrol, pterostilbene Red wine, grapes, peanuts, blueberries Anti‐aging effects, cardiovascular protection, anticancer properties, cognitive health improvement ~1 150–500 Kaur et al. (2024)
Carotenoids
Beta‐carotene Provitamin A compound Carrots, sweet potatoes, spinach, mangoes, pumpkin Supports immune function, enhances vision, promotes skin health 2–7 15–30 Sharma et al. (2024)
Luten Eye health, blue light filtration Kale, spinach, broccoli, corn, egg yolk Protects against age‐related macular degeneration (AMD), reduces eye strain 1–3 mg/day 10–20 mg/day Mrowicka et al. (2022)
Zeaxanthin Ocular protection, antioxidant properties Orange bell peppers, corn, goji berries, eggs Reduces the risk of cataracts and AMD, improves visual function 0.3–1.0 mg/day 2–10 mg/day Mrowicka et al. (2022)
Alpha‐linolenic acid (ALA) Precursor to EPA & DHA, supports metabolic functions Flaxseeds, chia seeds, walnuts, soybeans Cardiovascular protection, anti‐inflammatory effects 1.1 g/day (women) 1.6 g/day (men) as per US Institute of Medicine 2–5 g/day Rajaram (2014)
Eicosapentaenoic acid (EPA) Reduces systemic inflammation, regulates blood clotting Fatty fish (salmon, mackerel, sardines), krill oil, algae‐based supplements Lowers triglyceride levels, reduces risk of hypertension & atherosclerosis ~100–250 mg/day 500–4000 mg/day Nassar et al. (2023)
Docosahexaenoic acid (DHA) Essential for brain & retinal development, supports cognitive function Fatty fish, fish oil, algae oil Protects against neurodegenerative disorders (e.g., Alzheimer's), enhances memory & learning ~100–200 mg/day 300–2000 mg/day Ahmad et al. (2024)
Alkaloids and terpenoids
Alkaloids Caffeine, theobromine, morphine, nicotine, berberine Tea, coffee, cocoa, opium poppy, berberis, tobacco Antimicrobial, analgesic, neuroprotective, anti‐inflammatory, CNS stimulation Usually low or trace Moderate to high (1–1500 mg/day) Behl et al. (2022)
Terpenoids Limonene, curcumin, menthol, linalool, artemisinin Citrus peels, turmeric, rosemary, mint, lavender, artemisia Antioxidant, anti‐inflammatory, antimicrobial, anticancer, neuroprotective Low via diet (< 1–10 mg/day) 100–1000+ mg/day Sharma et al. (2017)

Modification of carotenoid content in staple crops through genetic modification is one of the biofortification strategies that have been explored to overcome vitamin A deficiency in susceptible populations (Naik et al. 2024). For instance, Golden Rice, a genetically modified crop developed to combat vitamin A deficiency (VAD) by producing provitamin A (β‐carotene) in the edible endosperm through the insertion of psy (from maize) and crtI (from Pantoea ananatis) genes. The β‐carotene in Golden Rice is efficiently converted to vitamin A in humans. It has been declared safe for human consumption by major regulatory agencies including US FDA and Health Canada based on assessments from the International Rice Research Institute (IRRI) (IRRI 2025; ISAAA 2018). The World Health Organization (WHO) considers biofortification, including genetic modification, a promising and sustainable strategy to combat micronutrient deficiencies in populations with limited dietary diversity. However, WHO highlights the need for rigorous safety assessments, adherence to Codex Alimentarius standards, long‐term monitoring, and community acceptance before issuing formal recommendations (WHO 2023).

2.3. Omega‐3 Fatty Acids as Essential Lipids for Brain and Heart Health

Omega‐3 fatty acids, a class of essential polyunsaturated fatty acids (PUFAs), are well recognized for their profound impact on cardiovascular, cognitive, and metabolic health (Figure 2). These bioactive lipids are predominantly found in fatty fish such as salmon, mackerel, and sardines, as well as in plant‐based sources like flaxseeds, chia seeds, and walnuts (Table 3).

FIGURE 2.

FIGURE 2

Sources and health benefits of omega‐3 fatty acids.

TABLE 3.

Overview of probiotics, prebiotics, and synbiotics, their sources, and key health benefits.

Category Key microorganisms/components Major food sources Health benefits References
Probiotics Lactobacillus, Bifidobacterium, Saccharomyces boulardii Yogurt, kefir, sauerkraut, kimchi, miso, kombucha Improves digestion, enhances immune response, reduces risk of IBS and IBD, restores gut flora after antibiotic use Kothari et al. (2019)
Prebiotics Inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), resistant starch Garlic, onions, bananas, whole grains, asparagus, chicory root Promotes growth of probiotics, enhances gut microbiota diversity, supports digestive health, reduces inflammation Victoria Obayomi et al. (2024)
Synbiotics Probiotic strains + Prebiotic fibers Fermented dairy with added prebiotics, functional foods, dietary supplements Improves microbiota composition, enhances nutrient absorption, potential role in mental health via gut‐brain axis Markowiak and Śliżewska (2017)

2.4. Alkaloids and Terpenoids as Bioactive Compounds With Medicinal Properties

Alkaloids and terpenoids are two significant classes of bioactive compounds found in plants, each with diverse pharmacological properties. Alkaloids are nitrogen‐containing secondary metabolites that exhibit antimicrobial, analgesic, neuroprotective, and anti‐inflammatory activities. These compounds are prevalent in various medicinal plants, as well as in widely consumed beverages such as tea, coffee, and cocoa (Heinrich et al. 2021). Notable alkaloids include caffeine, theobromine, and morphine, each of which exerts distinct physiological effects. Caffeine, for instance, acts as a central nervous system stimulant, enhancing alertness and cognitive function, while morphine is a potent analgesic used in pain management (Evans et al. 2025) (Table 2).

Terpenoids, also known as isoprenoids, represent the largest class of plant‐derived natural compounds with extensive medicinal and nutritional applications. These lipophilic compounds contribute to the aroma, flavor, and pigmentation of many plants and are commonly found in essential oils, citrus fruits, and herbs such as rosemary and mint (Ludwiczuk et al. 2017). Terpenoids possess antioxidant, anti‐inflammatory, antimicrobial, and anticancer properties, making them valuable in pharmaceutical and nutraceutical industries (Siddiqui et al. 2024). Compounds such as limonene, found in citrus peels, have been studied for their potential role in cancer prevention, while curcumin, a bioactive terpenoid from turmeric, exhibits strong anti‐inflammatory and neuroprotective effects. With the rising interest in plant‐based medicines, the extraction, synthesis, and bioavailability enhancement of alkaloids and terpenoids remain key research areas for developing novel therapeutic agents (Koolaji et al. 2020) (Table 2).

2.5. Probiotics, Prebiotics, and Their Role in Gut Microbiota

The gut microbiome plays a pivotal role in human health, and probiotics and prebiotics are essential modulators of microbial diversity and function (Table 3).

Recent research highlights the gut‐brain axis as a key area of interest, suggesting that probiotics and prebiotics may influence mental health by modulating neurotransmitter production and reducing inflammation.

3. Mechanism of Action

3.1. Antioxidant Activity

Antioxidant activity is an ability of a molecule to prevent the oxidation of other useful molecules in the body, which results in the generation of harmful free radicals. Antioxidants are capable of donating electrons to free radicals, thus neutralizing these radicals and averting them from causing cellular and tissue damage (Figure 3) (Lu et al. 2021; Munteanu and Apetrei 2021). In functional foods, antioxidants are predominately phenolic in nature, such as flavonoids, polyphenols, and omega‐3 fatty acids, which chelate pro‐oxidant ionic metals and scavenge reactive oxidative species (ROS), thus reducing inflammation and oxidative stress (Abeyrathne et al. 2022; Uro‐Chukwu et al. 2025).

FIGURE 3.

FIGURE 3

Principal mode of action of antioxidants.

3.1.1. Role of Dietary Antioxidants in Different Body Mechanisms

The inhibition of oxidative stress is achieved by some common dietary antioxidants such as vitamin C and E, carotenoids, and polyphenols that donate electrons to stabilize free radicals, including peroxyl radicals (ROO·), superoxide anions (O2) and hydroxyl radicals (OH·) (Hossain et al. 2022; Vignesh et al. 2024). Tomato‐based products that are enriched with carotenoid lycopene lower cardiovascular disease risk by reducing oxidative stress. Dietary fibers modulate enzymatic defense systems endogenously, such as superoxide dismutase (SOD), which catalyzes dismutation of superoxide radicals into hydrogen peroxide, which is broken down into oxygen and water (Figure 4) (Eddaikra and Eddaikra 2021; Islam et al. 2022).

FIGURE 4.

FIGURE 4

Dismutation of superoxide radicals into hydrogen peroxide by superoxide dismutase encapsulated in dietary fibers. https://www.canva.com/design/DAGjAUUKI40/WR2xVIX22XTqa6P0mVlX‐g/edit?utm_content=DAGjAUUKI40&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

Although antioxidants play a crucial role in reducing excessive reactive oxygen species (ROS) and preventing oxidative damage, it is important to recognize that moderate ROS levels are physiologically essential. ROS act as signaling molecules in pathways regulating cell proliferation, differentiation, immune responses, and stress adaptation. Complete elimination of ROS can disrupt these redox‐sensitive signaling cascades, impair adaptive responses, and compromise cellular homeostasis. Therefore, the aim of antioxidant‐based interventions should be to maintain redox balance, preserving beneficial ROS‐mediated functions while preventing harmful oxidative stress (Hasanuzzaman et al. 2020; Poljsak et al. 2013).

3.2. Anti‐Inflammatory Effects

Inflammation is a complicated physiological response that arises when the human body reacts to different adverse stimuli, such as toxic agents, cellular injury, and pathogenic microbes. Chronic inflammation significantly leads to cancer, diabetes, cardiovascular disease, and neurodegenerative diseases (Elbandy 2022; Ma et al. 2025). Functional foods have bioactive compounds that exert anti‐inflammatory benefits through several molecular mechanisms (Martirosyan et al. 2022; Mondal et al. 2021).

3.2.1. Pro‐Inflammatory Cytokines Inhibition

Pro‐inflammatory cytokines such as interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐alpha (TNF‐α) play an important role in the inflammatory response, which is being suppressed by functional food bioactives (Coutinho‐Wolino et al. 2022). Different bioactive compounds are known for their anti‐inflammatory responses in various reports. According to previous studies on Curcuma longa (common name: turmeric), its bioactive compound curcumin, also known as diferuloylmethane, possesses anti‐inflammatory properties. The study reveals that 10–20 μM of curcumin concentrations significantly reduce IL‐6 and TNF‐α secretion in lipopolysaccharides (LPS)‐stimulated macrophages by inhibiting NF‐κB pathway and toll‐like receptors (TLR4) activation (Guimarães et al. 2013).

Moreover, omega‐3 fatty acids are also known to suppress inflammatory responses in living cells. Meta‐analytic data reported that daily intake of 30 mg of omega‐3 fatty acids for 12 weeks significantly reduced IL‐6 levels by 1.87 pg/mL and TNF‐α by 2.11 pg/mL in a clinical trial on mice models (Djuricic and Calder 2021; Kavyani et al. 2022; Roşian et al. 2025). In another clinical study on humans, omega‐3 fatty acid supplementation (2–4 g/day EPA and DHA) led to a 24%–36% reduction in serum IL‐6 and TNF‐α in patients with rheumatoid arthritis and cardiovascular disease (Table 4) (Banaszak et al. 2024; Bodur et al. 2025).

TABLE 4.

Mechanism of action of various functional food bioactives in the inhibition of pro‐inflammatory cytokines.

Bioactive compound Food sources Mechanism of action References
Curcumin Turmeric Inhibits ofNLRP3 and NF‐κBInflammasome (10–20 μM) Barakat et al. (2023), Guimarães et al. (2013)
Quercetin Onions, garlic Inhibits NF‐κB and NLRP3 inflammasome activation (5‐50 μM) Chojnacka and Lewandowska (2023), Djuricic and Calder (2021)
Resveratrol Berries, grapes Activation of SIRT1 for inhibiting cytokine expression Zhang et al. (2022), Banaszak et al. (2024)
Omega‐3 fatty acids Fatty fish Inhibition of NF‐κB signaling by activation of PPAR‐γ (2–4 g/day) Sharma et al. (2024), Cui et al. (2019)
Flavonoids Fruits and vegetables Modulation of NF‐κB, AP‐1, PPAR, Nrf2, and MAPK pathways Behl et al. (2021)
Terpenes Mushrooms Inhibition of TLR4 activation (50–100 μg/mL) Spano et al. (2022), Fakhri et al. (2022)

3.2.2. NF‐κBsignaling Pathway Modulation

NF‐κB pathway plays an important role in regulating inflammation, with its sustained activation associated with various ailments like neuroinflammation, cancer, and cardiovascular disease (Kannan et al. 2025). According to a recent study, 10 μΜ of curcumin was found to inhibit IκB kinase in murine macrophage cell lines (RAW264.7), thus preventing phosphorylation and degradation of IκB, hence blocking nuclear translocation of NF‐κB (Figure 5). Similarly, 25 μM of resveratrol inhibited NF‐κB activation in LPS‐stimulated THP‐1 human monocytes, leading to a significant decrease in TNF‐α by 40% (Fakhri et al. 2022; Patel et al. 2020). A polyphenolic compound, resveratrol that is found in grapes and red wine, averts activation of NF‐κb in monocytes, which results in reduced secretion of IL‐1β and TNF‐α (Chojnacka and Lewandowska 2023).

FIGURE 5.

FIGURE 5

Inhibition of NF‐κBby curcumin. https://www.canva.com/design/DAGjFRImsNo/qR00qEtcxaAihr‐QyFuf4w/edit?utm_content=DAGjFRImsNo&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

A well‐controlled study in mice fed a high‐fat diet (HFD) with resveratrol supplementation (30 mg/kg/day) demonstrated significant metabolic and anti‐inflammatory benefits, including decreased hepatic mRNA expression of NF‐κB, IL‐6, TNF‐α, and IL‐1β, increased SIRT1 expression, improved lipid metabolism, and reduced markers of NAFLD (e.g., liver triglycerides and steatosis) (Andrade et al. 2014; Yasmin et al. 2025; Zhou et al. 2019).

3.2.3. MAPK Pathway Regulation

Mitogen‐activated protein kinase (MAPK) pathway is vital for cytokine synthesis by transmitting inflammatory signals (Ganguly et al. 2023). According to research, epigallocatechin gallate (EGCG) from green tea (25–50 μM) inhibits phosphorylation of p38 MAPK in macrophages, resulting in reduced IL‐1β and TNF‐α levels (Behl et al. 2021). Quercitin (30 μM) present in onions and apples inhibits the activation of JNK signaling in LPS‐stimulated RAW264.7 macrophages, contributing to decreased iNOS and COX‐2 expression (Cui et al. 2019; Sahu and Rawal 2024).

3.3. Gut Microbiome Modulation

Functional nutrients can modulate the gut microbiome by selectively promoting the growth of beneficial microbes, thereby influencing metabolic homeostasis. These nutrients play an important role in preventing gut microbiome imbalance by inhibiting pathogenic microbes and promoting the proliferation of bioactive microbial metabolites (Dahiya and Nigam 2022; Green et al. 2020). Prebiotics, including resistant starch, fructans, and galactooligosaccharides, act as substrates for beneficial gut bacteria such as Lactobacillus and Bifidobacterium. These bacteria produce short‐chain fatty acids (SCFA) such as butyrate, acetate, and propionate that maintain intestinal barriers (Zhang et al. 2023). Dietary fiber fermentation lowers oxidative stress and inflammation by strengthening the intestinal barrier and enhancing the integrity of tight junctions (Gao et al. 2022).

3.3.1. Role of Dietary Polyphenols in Balancing Gut Microbiota

Polyphenol‐rich foods such as blueberries, cranberries, tea, and cocoa enhance the proliferation of Akkermansia muciniphila, Lactobacillus sp., and Bifidobacterium bifidum as a prebiotic effect while suppressing obesity‐associated microorganisms and enhancing short‐chain fatty acid levels (Liu et al. 2020). They also play a significant role in suppressing harmful bacteria by inhibiting PBP2 and PBP4, which lead to a reduction in peptidoglycan cross‐linking and an increase in lysine, as well as the creation of an acidic environment in the gut by the deletion of H + ‐ATPase5, proton donation, and proton pump impairment (Figure 6). Flavonoids from citrus fruits and polyphenols from green tea have been shown to modulate bile acid metabolism and improve cholesterol homeostasis. In addition, omega‐3 fatty acids lead to bile acid conversion and gut microbial diversity, thus promoting inflammation‐free microbial diversity (Wang et al. 2024).

FIGURE 6.

FIGURE 6

Impact of dietary polyphenols on gut microbiome. https://www.canva.com/design/DAGjG9xB8F4/0e6SeBhsRr3rbnbZKMw39g/edit?utm_content=DAGjG9xB8F4&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

3.4. Enzyme Inhibition

Enzymes are essential for human survival; any malfunction in them can cause overexpression or underexpression of enzymes necessary for normal functioning. This can be stopped by the formation of an enzyme‐inhibitor complex that inhibits aberrant enzyme functioning (Phull et al. 2022; Saleem et al. 2024). Functional food phytochemical constituents regulate crucial enzymes, thus lowering the risk of diseases and promoting improved health. A number of functional foods contain key bioactive components that exert therapeutic effects by obstructing enzymes involved in carbohydrate metabolism, digestion of lipids, oxidative stress, and inflammatory pathways (Hou et al. 2024).

3.4.1. Pancreatic Lipase Inhibition

Pancreatic lipase plays a crucial role in managing weight and the breakdown of dietary fats (Lim et al. 2022). Control of obesity and dyslipidemia can be managed via pancreatic lipase inhibition by functional bioactives, which is an effective approach. Grapes contain proanthocyanidins that bind to the active site of this enzyme, limiting its ability to break down into free fatty acids (Figure 7). Likewise, saponins in fenugreek and different legumes form insoluble complexes by interacting with dietary lipids, thereby restraining the bioavailability of fats (Jamai et al. 2024).

FIGURE 7.

FIGURE 7

Inhibitory potential of pancreatic lipase by grape polyphenols. https://www.canva.com/design/DAGjLT3ibvs/AsxAmVlj7ADpCuFB5rULCg/edit?utm_content=DAGjLT3ibvs&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

3.4.2. Inhibition of Butyryl Cholinesterase (BChE) and Acetyl Cholinesterase (AChE)

Inhibition of butyryl cholinesterase and acetyl cholinesterase, enzymes linked to Alzheimer's disease pathology, is derived from functional food bioactives. According to research, about 12 active ingredients from Ganoderma amboinense, such as lucidenic acid F and ganoderic acid, exhibit AChE inhibition for Alzheimer's management. Enzymatic hydrolysates present in yellow field pea proteins, particularly those treated with flavourzyme, pepsin, and alcalase, resulted in inhibition of AChE activity by 20%–30% (Hou et al. 2024). Similarly, extracts of Limonium spathulatum showed substantial inhibitory action against BChE, with IC50 values of about as low as 0.03 mg/mL (Grzelczyk et al. 2023). However, despite promising in vitro enzyme inhibition, it is important to note that many phytochemicals face limited permeability across the blood–brain barrier, which can restrict their therapeutic efficacy in neurological disorders like Alzheimer's disease (Paramanick et al. 2022).

3.4.3. Inhibition of Carbohydrate Digesting Enzymes

α‐Amylase and α‐glucosidase are carbohydrate‐digesting enzymes that are mandatory for the digestion and absorption of nutrients. However, their overexpression may lead to several metabolic issues (Vyas et al. 2024). Their inhibition is a strategy for controlling postprandial hyperglycemia, which is the major risk for type 2 diabetes. Plant polyphenols such as diosmin, curcumin, and morin have the ability to constrain carbohydrate‐digesting enzymes. The extract of Gardenia jasminoides plays an important role in impeding α‐amylase and α‐glucosidase, thus reducing the fasting blood glucose level and high‐fat diet lipids. Epigallocatechin gallate (EGCG) and quercetin have the potential to reduce starch digestion by inhibition of α‐amylase activity (Li et al. 2025; Wu et al. 2024).

3.4.4. Angiotensin‐Converting Enzyme (ACE) Inhibition

Angiotensin‐converting enzyme converts angiotensin I to angiotensin II, a strong vasoconstrictor that is vital for the maintenance of blood pressure (Khurana and Goswami 2022). Peptides that are derived from fish proteins, fermented dairy, and soy emulate the action of pharmacological ACE inhibitors, thus inhibiting the active site of the enzyme and preventing the synthesis of angiotensin II synthesis (Figure 8). Flavonoids from green tea, cocoa, and grapes increase nitric oxide inhibition along with the inhibition of ACE, leading to improved endothelial function by vasodilation. Meta‐analytical evidence suggests that 3–5 g peptide/day may be effective in exerting antihypertensive effects without adverse outcomes (Ahmad et al. 2023; Hadi et al. 2022).

FIGURE 8.

FIGURE 8

Anti‐hypertensive mechanism of bioactive peptides in functional food. https://www.canva.com/design/DAGjY‐O9P98/9cm2hhhkbeAAimd3Tzvs6A/edit?utm_content=DAGjY‐O9P98&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

4. Applications in Functional Food Development

4.1. Fortified Beverages

Beverage is a liquid drink meant for human consumption in order to quench one's thirst, and it constitutes human culture. Fortified beverages, also known as designer beverages, are one of the major advancements in the development of functional food, and they provide increased nutritional advantages by incorporating different bioactive ingredients (Ajeeshkumar et al. 2021). These drinks are made to meet certain health needs, such as boosting probiotic viability, improving antioxidant activity, and supplementing essential nutrients. Functional ingredients, including probiotics, dietary fibers, omega‐3 fatty acids, and vitamins, are most commonly used in the fortification of beverages (Afzal et al. 2022).

4.1.1. Examples and Applications

Emmer‐based fermented beverages enriched with fruit juices (e.g., blueberry, aronia) are non‐dairy probiotic alternatives, especially suitable for lactose‐intolerant individuals. These beverages, when fortified with Lactiplantibacillus plantarum and fruit juices like blueberry or aronia, deliver total phenolic contents and antioxidant capacities while maintaining probiotic viability above during refrigerated storage (Dimitrellou et al. 2021; Pannerchelvan et al. 2023). Fortified juices are the valuable alternatives that can be consumed by lactose‐intolerant individuals. Evolus from Valio Finland is a commercial beverage that is supplemented with bioactive peptides from Lactobacillus helveticus (Jauhiainen et al. 2005). Synbiotic beverages that are fortified with prebiotics and cereal sprouts demonstrate enhanced sensory acceptance and probiotic viability, catering to health‐conscious consumers (Kheto et al. 2025).

4.2. Functional Dairy Products

Functional dairy products have become an essential component of the food industry, which contributes to human health beyond mere nutrition. The adaptability of dairy ingredients, along with advancements in the dairy industry, has enabled the development of a diverse array of functional dairy products (Khalaf et al. 2021). These products can easily be incorporated with essential bioactive components, including bioactive peptides, prebiotics, probiotics, and other functional ingredients, that make a versatile dairy products in health‐promoting foods (Lamsar and Abhilasha 2023).

4.2.1. Probiotics and Prebiotics Dairy Products

The dairy matrix offers a protective milieu for probiotic bacteria along with prebiotics, enhancing their survival during storage and processing (Ali et al. 2022). According to studies, yogurt is fortified with Bifidobacterium bifidum, Lactobacillus acidophilus , and Streptococcus thermophiles to balance the gut microbiome.

Activia by Danone's yogurt, which is a functional food, contains probiotic strain Bifidobacterium animalis DN‐173010 and insulin. Clinical studies report faster intestinal transit and symptom relief in individuals with IBS.

Yakult, a fermented dairy drink, delivers Lacticaseibacillus paracasei strain Shirota (LcS) to improve digestion (according to Yakult Philippines 2019). Studies show regular intake reduces constipation episodes, improves gut immunity, and is consumed in over 40 countries (Lamsar and Abhilasha 2023).

4.2.2. Fortified Dairy Based Bioactive Peptides and Other Dairy Functional Products

The philosophy of science aims to enhance the quality of human life, and for many years, bioactive peptides have been used as a component of functional food to improve this quality. Bioactive peptides are biological entities that are buried inside precursor proteins and become functional during cleavage of that protein (Akbarian et al. 2022). Peptides derived from casein and whey have shown to inhibit ACE; therefore, reducing blood pressure.

Calpis, from Japan, contains Val‐Pro‐Pro (VPP) and Ile‐Pro‐Pro (IPP) tripeptides, which inhibit ACE activity and are clinically shown to reduce systolic blood pressure in mildly hypertensive individuals (Table 5).

TABLE 5.

Some commercially available functional dairy products.

Brand/product name Type of product Active ingredient Nutrient content/serving Consumer outcomes Manufacturer References
Probiotics
Yakult Fermented milk Lactobacillus casei Shirota 160 cal, 1 g protein, 14 g carbohydrates Prevents constipation and gastrointestinal infections Yakult Honsha Co., Japan Mellentin (2023)
Biobalance Fermented milk Bifidobacteriumlactis 7 cal, 1 g of total carbohydrates Facilitates intestinal transit Dos Pinos R.L., Costa Rica Ali et al. (2022)
Activia Yogurt Bifidobacteriumanimalis DN‐173, Bifidusregularis, Bifidusactivo 90 cal, 1.5 g of total fats, 1 g of saturated fats, 5 mg of cholesterol, 55 mg of sodium, 15 g of carbohydrates, 12 g of total sugars, 4 g of proteins Controls irritable bowel syndrome Groupe Danone, France Ali et al. (2022)
Prebiotics
Orafti Soluble powder Inulin/oligofructose 101 kcal, 1.5 g total fat, 1 g saturated fats, 5 mg cholesterol, 55 mg sodium, 20 g total carbohydrates, 12 g total sugars, 4 g proteins Improves intestinal flora BENEO Group, Belgium Kumar et al. (2022)
Hilma Fiber + enzyme supplement Acacia gum, psyllium husk 20 cal, 6 g total carbohydrates; 6 g dietary fiber, 100 mg enzyme blend Supports bowel regularity, reduces bloating, improves digestion for sensitive stomachs; prebiotic support for gut microbiome Hilma, USA Hilma (2020)
Bioactive peptides
Recaldent Ingredient Caseinophosphopeptides and amorphous calcium phosphate 18.6 kcal per 8 pastilles (10.4 g) Anti‐cariogenic activity Cadbury Co. UK Ali et al. (2022)
Calpis Sour milk Hypotensive tripeptides ~50 kcal, ~12 g carbohydrates/sugars, ~15 mg sodium, ~20 mg calcium Reduces blood pressure Calpis Co., Japan Peighambardoust et al. (2021)
Animal‐Derived Functional Compounds from By‐products
Collagen peptides (from fish) Animal‐derived (waste‐based) Marine collagen peptides 369 cals, 90 g of proteins Enhances skin elasticity, supports joint health Vital proteins (marine collagen) Steele (2022)
Chitosan‐based drinks Functional animal product Chitosan (from shrimp/crab shells) 3 kcal, 0.5 g total carbohydrates, 0.5 g dietary fiber Fat‐binding, cholesterol‐lowering, weight management, digestive health Various nutraceutical companies Ylitalo et al. (2002)
Eggshell membrane hydrolysates Nutraceutical capsule/drink Collagen, glycosaminoglycans 66 mg of collagen and 100 mg of hyaluronic acid Joint support, reduces inflammation, improves connective tissue health Multiple nutraceutical brands Ruff et al. (2009)
BioPURE‐GMP Nutraceutical capsule/drink Glycomacropeptides (GMP) 100 cals, 16 g of proteins, 3 g of fats, and 2 g of carbohydrates, 75 mg of cholesterol Enhances gut barrier function, exhibits anti‐carcinogenic properties Davisco Foods International, USA Rackerby et al. (2024)

Research also proved that consumption of omega‐3 fortified milk for approximately 12 weeks led to improved brain function in older individuals. In Canada and the US, milk is supplemented with vitamin D to prevent osteoporosis and rickets (Peighambardoust et al. 2021).

4.2.3. Functional Animal‐Derived Products From Wastes

Bioactive compounds from animal waste streams and by‐products are being recycled into functional foods and nutraceuticals in response to concerns about sustainability and the circular economy. These include:

Fish‐derived collagen peptides (from skin, scales, and bones) have been added to drinks, jellies, and capsules to promote healthy joints and skin. Research shows that consistent consumption improves skin elasticity and lessens joint pain (Steele 2022).

Chitosan (from shrimp and crab shells) has been used in fat‐binding drinks, antimicrobial packaging, and dietary supplements that lower cholesterol and help in weight management (Ylitalo et al. 2002).

Eggshell membrane hydrolysates, enriched with collagen and glycosaminoglycans, are used in functional drinks and capsules to support connective tissue and joints (Ruff et al. 2009).

Glycomacropeptides (GMP) from cheese whey are present in products like BioPURE‐GMP. It shows anti‐carcinogenic properties and enhances gut barrier function (Rackerby et al. 2024).

These innovations demonstrate how animal‐derived by‐products are being transformed into high‐value health‐promoting ingredients, reducing waste and enhancing sustainability in the food sector.

4.3. Poultry as a Source of Functional Compounds

Poultry products (e.g., ducks, chickens, and turkeys), beyond providing basic nutrition, are a significant source of functional compounds that include antioxidants, bioactive peptides, and vital nutrients like omega‐3 fatty acids and amino acids (Romero‐Garay et al. 2022).

The cardiovascular benefits of omega‐3‐enriched eggs have recently drawn the attention of the researchers. It has been reported that hens supplemented with flaxseed or fish oil exhibited enhanced content of alpha‐linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) in their eggs. This provides a practical way to raise omega‐3 intake in the general population (Vlaicu et al. 2021).

Additionally, carotenoids like lutein and zeaxanthin, which are critical for eye health, can be delivered through poultry products. Adding carotenoid‐rich feed ingredients, such as algae or marigold extract, improves carotenoid content and yolk color of eggs (Dansou et al. 2023).

Antioxidant capacity and vitamin enrichment in poultry can be manipulated through dietary strategies. For example, the inclusion of plant‐derived polyphenols or vitamin E in poultry feed not only improves the oxidative stability of meat and eggs but also potentially enhances their health‐promoting properties for consumers (Matumoto‐Pintro et al. 2017).

4.4. Snack Foods

The increased demand for healthy, on‐the‐go food options has fueled innovation in formulations of functional snacks, thus integrating scientifically validated ingredients to boost nutritional profile (Krüger et al. 2022). Researchers formulated a snack bar which contained a blend of 25% oats, 15% banana peel powder, and 60% amaranth grain, involving all the essential components like phenolics, antioxidants, β‐glucan, and minerals. Thermogravimetric analysis revealed that its active components are stable at high temperatures, thus preserving functional capabilities. Sensory evaluations of indicated that this bar could be stored for about 60 days without being contaminated and also has both nutritional and economic benefits (Boukid et al. 2022).

Although using banana peels provides a nutrient‐rich and sustainable alternative, there are certain limitations associated with its use (Deb et al. 2022). Potential issues include the indigestibility of some fibrous components and the presence of heavy metals (such as lead and cadmium) from environmental exposure, which require careful regulatory review to guarantee food safety and consumer acceptance. These factors must be addressed for the commercialization of functional innovations (Yasin et al. 2025).

4.4.1. Bioactive Components Containing Functional Food Snacks

Residues of Hibiscus sabdariffa, significantly containing flavonoids and phenolics, were incorporated into snack crackers to boost their antioxidant potential DPPH scavenging activity potential (Chew et al. 2024). For example, Dang coconut chips contain magnesium and selenium as minerals that activate glutathione peroxidase, which combats oxidative stress. Similarly, Sunroot (Jerusalem artichoke) is supplemented with snack foods due to its rich content of antioxidants and insulin (Nazzaro et al. 2025). Cannabis sativa contains a bioactive component, cannabinoids, as a functional component, and the inclusion of this plant seed in the dough of gluten‐free bread and crackers that is rich in iron contributes toward reducing disease risk (Krüger et al. 2022).

However, it's crucial to note that only hemp‐derived strains of Cannabis sativa with low optimized levels of tetrahydrocannabinol (THC) are utilized in culinary applications. There is no risk of psychosis or addiction because these hemp seeds don't contain large amounts of cannabinoids like CBD or THC (EFSA 2022; FDA 2024). Strict regulations govern the use of hemp‐derived food ingredients; for example, the European Food Safety Authority (EFSA) and the US Food and Drug Authority (FDA) permit the use of hemp seeds in food products as long as the THC content stays below predetermined limits (usually ≤ 0.3%) and no cannabinoid extraction is done (EFSA 2022; FDA 2024).

4.5. Dietary Supplements

The global rise in chronic ailments, consumer demands for health‐promoting foods, and nutrient deficiencies has resulted in the expansion of dietary supplement‐enriched functional foods. According to the 1994 Dietary Supplement and Education Act, nutritional additives include vitamins, minerals, amino acids, proteins, fatty acids, and fiber, which are known as dietary supplements (Alongi and Anese 2021). Vitamin D dairy products have been demonstrated to improve immunological and bone health. Iron‐supplemented cereals have been developed to fight anemia, especially in populations where iron deficiency is highly prevalent. PUFA ꞷ‐3 and ꞷ‐6 and MUFA ꞷ‐9 in functional foods reduce the chance of inflammatory disease and coronary heart disease. Coenzyme Q‐10 is an internal lipophilic that is effective as a dietary supplement in functional food effective for human fitness and skin smoothness (Figure 9). Resveratrol is a polyphenol that is found in grapes, integrated into beverages for longevity‐promoting properties (Boggia et al. 2020).

FIGURE 9.

FIGURE 9

Functional food‐based dietary supplements. https://www.canva.com/design/DAGjZEHPiwM/moppQ8cF6fhMfJcCjyhp‐g/edit?utm_content=DAGjZEHPiwM&utm_campaign=designshare&utm_medium=link2&utm_source=sharebutton.

5. Market of Different Types of Functional Foods

The global functional food market has emerged as one of the fastest‐growing sectors in the food industry, driven by consumer demand for preventive health solutions, rising healthcare costs, and increasing awareness of diet‐related diseases. According to Euromonitor, the global market for functional foods is estimated to be worth USD 177.4 billion in 2021 and expected to be USD 219.5 billion by 2026 (Sørensen et al. 2022; Tables 6 and 7). This discrepancy reflects differences in the classification of functional foods rather than an actual decline in market size.

TABLE 6.

Global market value of functional foods.

Category Market highlights References
Global market shares
Global market value (2021) USD 177.4B, Projected USD 219.5B by 2026 Sørensen et al. (2022)
Pandemic impact Growth rose from 0.3% (2019–20) to 5% (2020–21), driven by health awareness (e.g., vitamin D fortification) Sørensen et al. (2022)
Europe (2021) Western Europe: USD 23B, Eastern Europe: USD 5.2B. UK (20% of EU), Germany (14%), France (13%), Spain (12%), Italy (11%) Sørensen et al. (2022), Vicentini et al. (2016)
Latin America Mexico: USD 12.7B (2011) → USD 16.3B (2015), Rapid expansion: Brazil +10% annually Sørensen et al. (2022), Vicentini et al. (2016)
Other regions

Saudi Arabia, Israel, and South Africa show higher functional food potential

Eastern Europe has fragmented functional food market

Within the region, Russia dominates the market, accounting for 51% of all functional food sales in Eastern Europe

Sørensen et al. (2022), Vicentini et al. (2016)

Note: Bold values highlight key market sizes, growth rates, and dominant regional contributions.

TABLE 7.

Types of beneficial functional foods available in the market with brand names.

Product/functional food Type Key bioactive compound(s) Company/brand Regional availability Retail price range (USD) Reported health benefits References
Activia (probiotic yogurt) Dairy/yogurt Bifidobacteriumanimalis subsp. Lactis Danone (Dannon) USA, EU, APAC $1.0–$2.5 (single cup) Supports digestive health; reduces minor GI discomfort Danone (2023)
Yakult (probiotic drink) Fermented beverage Lactobacillus casei Shirota Yakult Honsha Global (major markets) $0.8–$1.8 (single bottle) Supports gut microbiota and regularity Kato‐Kataoka et al. (2016)
DanActive/Actimel Fermented beverage L. casei strains + vitamins D/B6 Danone USA, EU, APAC $1.0–$2.0 (single bottle) Immune support; digestive health Danone (2023)
Special K (fortified cereal) Cereals Added vitamins & minerals (iron, B vitamins) Kellogg's Global $3–$6 (box) General micronutrient fortification kelloggs.co.uk, n.d.
Eggland's Best (Omega3 EGGS) Eggs Omega3 fatty acids (ALA, EPA/DHA) Eggland's Best USA, EU markets $3.5–$6.5 (dozen) Increased omega3 intake for CV health Michella and Slaugh (2000)
GT's SYNERGY Kombucha Kombucha Live cultures, tea polyphenols GT's Living Foods USA, EU, APAC (selected) $3–$5 (bottle) Gut health, antioxidants GT's Living Foods
Beyond Burger (plant based patty) Plant based meat Pea/rice proteins; fortified iron Beyond Meat Global (major retailers) $4–$8 (pack) Protein alternative with lower sat fat Beyond Meat (2024)
Quest protein bars Snack bar High protein (whey/milk isolates), fiber Quest Nutrition USA, EU $1.8–$3.5 (bar) Muscle maintenance, satiety Quest Nutrition (2024)
Manitoba harvest hemp hearts Seeds/toppings ‐Omega3 & omega6 fatty acids, plant protein Manitoba Harvest North America, EU (selected) $6–$12 (8 oz) Plant protein & essential fatty acids Manitoba Harvest Hemp Foods (2025)
Huel (meal replacement) ‐Meal replacement Powder/ready to drink Balanced macros +27 essential vitamins & minerals Huel Ltd. Global (online + retailers) $2.0–$4.5 per meal equivalent Complete nutrition/weight management HuelLimited (2015–2025)
Ensure (clinical nutrition) Nutrition shake Proteins, vitamins & minerals (27+), ALA in some formulations Abbott Nutrition Global $1.5–$3.5 (bottle) Clinical nutritional support; elderly nutrition Abbott (2025)
Oatly (fortified oat milk) Plant based milk Added calcium, vitamin D, B12 Oatly Global (major markets) $2.5–$5 (carton) Dairy alternative with fortification oatly.com, n.d.
Chobani (probiotic yogurt lines) Dairy/yogurt Live cultures (probiotics) Chobani USA, select international $1.0–$2.5 (cup) Digestive health; protein‐rich yogurt Chobani (2024)
Alpro (fortified plant drinks) Plant based beverage Vitamins & minerals (Ca, B12, D) Alpro (Danone) EU, UK, APAC $2–$4 (carton) Dairy alternative with micronutrients Alpro (2025)
Nature's Bounty Omega3 (supplement) Dietary supplement EPA/DHA fish oil Nature's Bounty Global $8–$20 (bottle) Cardiovascular & cognitive support Bounty (2025)
Optimum Nutrition Gold Standard Whey (Protein) Sports nutrition Whey protein isolate/concentrate Optimum Nutrition (Glanbia) Global $1.0–$2.5 per serving Muscle recovery and performance Optimum Nutrition (2025)
S‐26 Probiotic Infant Formula Infant nutrition Probiotic strains (varies by formulation) Wyeth/Nestlé/Mead Johnson variations Selected regions $20–$60 (tin) Gut health in infants (formulation‐specific claims) Nestlé (2025)
Olly (multivitamin gummies) Dietary supplement/gummies Vitamins (multi blends) Olly USA, online global $8–$18 (bottle) General wellness, sleep/beauty formulations Unilever (2025)

6. Challenges Associated With Functional Foods

With compromised living standards and life expectancy, along with a high frequency of illnesses, nutrition plays an important role in maintaining human health. Scientists are working in collaboration to meet various food demands with associated therapeutic advantages, popularly known as functional food, promising in ensuring human well‐being and lowering the risk of illnesses (Lobine et al. 2022). The utilization of bioactive components and natural products in functional food development is a quickly expanding research area, providing significant health benefits beyond basic nutrition. However, multiple challenges must be addressed to secure their safety, efficacy, and commercial viability.

6.1. Bioavailability and Stability Issues

Bioavailability and stability are essential components in the development of functional foods, influencing their efficacy and shelf life (Mihociu et al. 2024).

Functional bioactive compounds like polyphenols, probiotics, peptides, and omega‐3 fatty acids often exhibit weak solubility, low permeability, and susceptibility to enzymatic destruction. Molecular size, hydrophobicity, and interaction with food matrices can also impede absorption (Mafe et al. 2025; Mihociu et al. 2024). Functional ingredients are susceptible to deterioration due to environmental variables such as temperature, pH, light, and oxygen. Oxidation, hydrolysis, and microbial contamination can all impair their structural integrity and efficacy. Stability is also a major concern during processing, storage, and digestion, requiring advanced delivery systems (e.g., nanoencapsulation, liposomes) (Mafe et al. 2025; Mihociu et al. 2024).

6.2. Standardization and Quality Control

Standardization and quality control are difficult for the formation of functional foods because of the complexity of bioactive substances, the unpredictability of raw materials, and inconsistent regulations. Exact analytical methods such as mass spectrometry and HPLC are necessary to guarantee consistent constituent composition; however, consistency is hampered by natural variances. Regional differences in regulations lead to discrepancies in safety evaluations, health claims, and labeling (Wani et al. 2023).

6.3. Regulatory and Safety Concerns

Functional foods are at the nexus of food and medicines, which presents challenges for their development due to complicated regulatory frameworks and safety issues. Regulatory agencies like the FDA and EFSA enforce strict rules on labeling, ingredient approval, and health claims; yet, regional variations make it difficult for products to be accepted on the international market. It takes sophisticated analytical techniques, such as mass spectrometry and microbiological testing, to guarantee the absence of pollutants, allergies, and poisons. It is also necessary to assess the long‐term consequences of intake through toxicological and clinical research (Vilas‐Boas et al. 2021).

6.4. Consumer Acceptances

Consumer acceptability and marketability, which are impacted by sensory qualities, perceived health advantages, and cost, are critical to the success of functional foods. Customers frequently reject functional food because of unfavorable flavor, texture, or appearance brought on by the addition of bioactive ingredients. Acceptance is further hampered by false information and mistrust over health claims, which makes open communication and claims supported by science necessary. Furthermore, market penetration is restricted by premium pricing brought on by expensive R&D and sophisticated processing methods (Grinberga‐Zalite et al. 2024).

6.5. Cost–Benefit Analysis of Functional Food Versus Regular Food

In addition to regulatory and safety concerns, economic feasibility remains a critical challenge influencing the widespread adoption of functional foods as they may carry a higher price point due to added bioactive components and enhanced processing. A comparative cost–benefit analysis indicates that preventive intake of functional foods could outweigh the initial cost when weighed against medical expenses for managing lifestyle‐related disorders; however, several studies suggest their long‐term cost‐effectiveness in reducing healthcare burdens associated with chronic diseases (Mehboob 2025; Michaud et al. 2017; Musich et al. 2016). Nonetheless, affordability and equitable access remain key barriers to consumer adoption, especially in low‐ to middle‐income populations (Zheng 2022).

6.6. Advancement in Biotechnology and Omics Approaches

The “omics technologies and biotechnology” have revolutionized the discovery, characterization, precision, and application of bioactive compounds and natural products in the functional food development. Various approaches are being used, including “omics”, synthetic biology, genetic engineering, and gene‐editing (Figure 10). These approaches provide a deeper knowledge of complex interactions between human biology and bioactive molecules, opening ways to ward targeted, validated, and effective functional foods (Nayak et al. 2021).

FIGURE 10.

FIGURE 10

Advancements in biotechnological and omics approaches.

6.7. Development of Smart Delivery Systems

Smart delivery system in functional food development enhancing the bioavailability, stability, and targeted release of sensitive bioactive compounds. Techniques such as liposomes, biopolymer‐based carriers, and nano‐emulsions protect bioactive compounds and improve their absorption. Additionally, smart packaging with intelligent and active features helps maintain product quality and increase shelf life, ensuring efficacy from production to consumption (Shishir et al. 2021).

6.8. Personalized Nutrition and Functional Foods

Personalized nutrition in the development of functional food offers tailored dietary solutions based on an individual's metabolism, lifestyle, and genetics. Researchers can develop customized functional food products by using tools such as nutrigenomics, microbiome analysis, and metabolomics that effectively target specific health conditions. Advancements in digital health and AI technologies further enable personalized recommendations and real‐time monitoring, enhancing the effectiveness, accessibility, and precision of functional nutrition (Dj Nevena et al. 2022).

6.9. Expanded Clinical Research and Regulatory Harmonization

Expanded clinical research and regulatory harmonization are crucial for advancing functional foods derived from natural products and bioactives. Strict clinical trials are essential to establish the safety, efficacy, and health benefits of these foods, paving the way for personalized nutrition and improved consumer acceptance. Meanwhile, regulatory harmonization creates global standards that ensure product quality and safety, facilitating innovation and international trade. By promoting collaboration among regulatory bodies, researchers, and industry stakeholders, these efforts will increase the development and trust in functional foods, ultimately meeting the growing consumer demand for health‐promoting products (Alongi and Anese 2021).

7. Future Prospect and Conclusion

Bioactive compounds obtained from natural food products and plant extracts possess incredible supplementary and medicinal properties. These biologically active components such as carotenoids, probiotics, prebiotics, and omega‐3 fatty acids have diverse health benefits such as anti‐inflammatory, antioxidant, enzyme inhibition activities, and gut microbiome modulation. Modern biotechnological and bioinformatics approaches have revolutionized the development, characterization, and targeted delivery of these therapeutically and nutritionally significant natural compounds.

In the future, integrating precision nutrition strategies (“omics” technologies and machine learning) may accelerate the discovery of new bioactive compounds and customized therapeutics. Sustainable sourcing, enhanced bioavailability through nanotechnology, and thorough clinical validation of these compounds will ensure their effectiveness, safety, and widespread adoption. To bridge the gap between conventional approaches and contemporary healthcare innovations, these natural compounds must also be transformed from research to mainstream health solutions in the market.

Author Contributions

A.H. and Z.A.: Conceived and designed the project; Z.A., S.S., A.H., E.Y., and M.R.: analyzed, wrote, revised, and proofread the manuscript. All authors contributed to the article and read and approved the final manuscript.

Ethics Statement

The authors have nothing to report.

Consent

The authors have nothing to report.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

The authors acknowledge the support provided by the Department of Biotechnology, Lahore University of Biological and Applied Sciences. All assistance and guidance were provided by the corresponding author, Dr. A.H.

Arshad, Z. , Shahid S., Hasnain A., Yaseen E., and Rahimi M.. 2025. “Functional Foods Enriched With Bioactive Compounds: Therapeutic Potential and Technological Innovations.” Food Science & Nutrition 13, no. 10: e71024. 10.1002/fsn3.71024.

Funding: The authors received no specific funding for this work.

Contributor Information

Ammarah Hasnain, Email: ammarahhasnain3@gmail.com.

Mehdi Rahimi, Email: mehdi83ra@gmail.com.

Data Availability Statement

Data used during the preparation of this manuscript is available within the article.

References

  1. Abbott. 2025. “Ensure® Original Vanilla Nutrition Powder.” https://www.ensure.com.
  2. Abeyrathne, E. D. N. S. , Nam K., Huang X., and Ahn D. U.. 2022. “Plant‐ and Animal‐Based Antioxidants' Structure, Efficacy, Mechanisms, and Applications: A Review.” Antioxidants 11, no. 5: 1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Afzal, M. F. , Khalid W., Akram S., et al. 2022. “Bioactive Profile and Functional Food Applications of Banana in Food Sectors and Health: A Review.” International Journal of Food Properties 25, no. 1: 2286–2300. [Google Scholar]
  4. Ahmad, H. , Khan H., Haque S., Ahmad S., Srivastava N., and Khan A.. 2023. “Angiotensin‐Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.” Journal of the Renin‐Angiotensin‐Aldosterone System 2023: 7890188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ahmad, S. , Ali M. D., Khardali A., et al. 2024. “Incredible Use of Omega‐3 Fatty Acids: A Review on Current Use and Future Prospective.” Journal of Young Pharmacists. 10.5530/jyp.2024.16.24. [DOI] [Google Scholar]
  6. Ajeeshkumar, K. K. , Aneesh P. A., Raju N., Suseela M., Ravishankar C. N., and Benjakul S.. 2021. “Advancements in Liposome Technology: Preparation Techniques and Applications in Food, Functional Foods, and Bioactive Delivery: A Review.” Comprehensive Reviews in Food Science and Food Safety 20, no. 2: 1280–1306. [DOI] [PubMed] [Google Scholar]
  7. Akbarian, M. , Khani A., Eghbalpour S., and Uversky V. N.. 2022. “Bioactive Peptides: Synthesis, Sources, Applications, and Proposed Mechanisms of Action.” International Journal of Molecular Sciences 23, no. 3: 1445. 10.3390/ijms23031445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ali, M. A. , Kamal M. M., Rahman M. H., et al. 2022. “Functional Dairy Products as a Source of Bioactive Peptides and Probiotics: Current Trends and Future Prospectives.” Journal of Food Science and Technology 59, no. 4: 1263–1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ali Redha, A. , Kodikara C., and Cozzolino D.. 2024. “Does Encapsulation Improve the Bioavailability of Polyphenols in Humans? A Concise Review Based on In Vivo Human Studies.” Nutrients 16, no. 21: 3625. https://www.mdpi.com/2072‐6643/16/21/3625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Alongi, M. , and Anese M.. 2021. “Re‐Thinking Functional Food Development Through a Holistic Approach.” Journal of Functional Foods 81: 104466. [Google Scholar]
  11. Alpro . 2025. “Fortified Plant Drinks.” https://www.alpro.com/uk.
  12. Andrade, J. M. , Paraíso A. F., de Oliveira M. V., et al. 2014. “Resveratrol Attenuates Hepatic Steatosis in High‐Fat Fed Mice by Decreasing Lipogenesis and Inflammation.” Nutrition 30, no. 7–8: 915–919. 10.1016/j.nut.2013.11.016. [DOI] [PubMed] [Google Scholar]
  13. Arshad, M. S. , Ahmad M. H., Khan M. K., et al. 2021. “Functional Foods and Human Health: An Overview.” In Functional Foods ‐ Phytochemicals and Health Promoting Potential, edited by Arshad M. S. and Ahmad M. H.. IntechOpen. [Google Scholar]
  14. Baker, M. T. , Lu P., Parrella J. A., and Leggette H. R.. 2022. “Consumer Acceptance Toward Functional Foods: A Scoping Review.” International Journal of Environmental Research and Public Health 19, no. 3: 1217. 10.3390/ijerph19031217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Banaszak, M. , Dobrzyńska M., Kawka A., et al. 2024. “Role of Omega‐3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) as Modulatory and Anti‐Inflammatory Agents in Noncommunicable Diet‐Related Diseases–Reports From the Last 10 Years.” Clinical Nutrition ESPEN 63: 240–258. [DOI] [PubMed] [Google Scholar]
  16. Barakat, M. , Syed N. K., Hasen E., et al. 2023. “The Effect of Natural Products on Inflammatory Cytokines Production and Secretion.” Phytomedicine Plus 3, no. 4: 100488. 10.1016/j.phyplu.2023.100488. [DOI] [Google Scholar]
  17. Behl, T. , Singh S., Sharma N., et al. 2022. “Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.” Molecules 27, no. 12. 10.3390/molecules27123705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Behl, T. , Upadhyay T., Singh S., et al. 2021. “Polyphenols Targeting MAPK Mediated Oxidative Stress and Inflammation in Rheumatoid Arthritis.” Molecules 26, no. 21: 6570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bodur, M. , Yilmaz B., Ağagündüz D., and Ozogul Y.. 2025. “Immunomodulatory Effects of Omega‐3 Fatty Acids: Mechanistic Insights and Health Implications.” Molecular Nutrition & Food Research 69, no. 10: e202400752. 10.1002/mnfr.202400752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Boggia, R. , Zunin P., and Turrini F.. 2020. “Functional Foods and Food Supplements.” Applied Sciences 10, no. 23: 8538. https://www.mdpi.com/2076‐3417/10/23/8538. [Google Scholar]
  21. Boukid, F. , Klerks M., Pellegrini N., et al. 2022. “Current and Emerging Trends in Cereal Snack Bars: Implications for New Product Development.” International Journal of Food Sciences and Nutrition 73, no. 5: 610–629. [DOI] [PubMed] [Google Scholar]
  22. Bounty, N. S. 2025. “Nature's Bounty.” https://naturesbounty.com/.
  23. Chew, L. Y. , Teng S. K., Neo Y. P., Sim Y. Y., and Chew S. C.. 2024. “The Potential of Roselle ( Hibiscus sabdariffa ) Plant in Industrial Applications: A Promising Source of Functional Compounds.” Journal of Oleo Science 73, no. 3: 275–292. [DOI] [PubMed] [Google Scholar]
  24. Chobani . 2024. “High Protein.” https://www.chobani.com/.
  25. Chojnacka, K. , and Lewandowska U.. 2023. “Inhibition of Pro‐Inflammatory Cytokine Secretion by Polyphenol‐Rich Extracts in Macrophages via NF‐κB Pathway.” Food Reviews International 39, no. 8: 5459–5478. 10.1080/87559129.2022.2071936. [DOI] [Google Scholar]
  26. Coutinho‐Wolino, K. S. , Almeida P. P., Mafra D., and Stockler‐Pinto M. B.. 2022. “Bioactive Compounds Modulating Toll‐Like 4 Receptor (TLR4)‐Mediated Inflammation: Pathways Involved and Future Perspectives.” Nutrition Research 107: 96–116. [DOI] [PubMed] [Google Scholar]
  27. Cui, S. , Wu Q., Wang J., Li M., Qian J., and Li S.. 2019. “Quercetin Inhibits LPS‐Induced Macrophage Migration by Suppressing the iNOS/FAK/Paxillin Pathway and Modulating the Cytoskeleton.” Cell Adhesion & Migration 13, no. 1: 1–12. 10.1080/19336918.2018.1486142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dahiya, D. , and Nigam P. S.. 2022. “The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods With Prebiotics Can Sustain Wellness and Alleviate Certain Ailments Like Gut‐Inflammation and Colon‐Cancer.” Microorganisms 10, no. 3: 665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Danone . 2023. “Danone Launches New Science‐Based Probiotic Supplement to Support Breastfeeding Experiences.” [Press Release].
  30. Dansou, D. M. , Zhang H., Yu Y., et al. 2023. “Carotenoid Enrichment in Eggs: From Biochemistry Perspective.” Animal Nutrition 14: 315–333. 10.1016/j.aninu.2023.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Deb, S. , Kumar Y., and Saxena D. C.. 2022. “Functional, Thermal and Structural Properties of Fractionated Protein From Waste Banana Peel.” Food Chemistry: X 13: 100205. 10.1016/j.fochx.2022.100205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dimitrellou, D. , Kandylis P., Kokkinomagoulos E., Hatzikamari M., and Bekatorou A.. 2021. “Emmer‐Based Beverage Fortified With Fruit Juices.” Applied Sciences 11, no. 7: 3116. https://www.mdpi.com/2076‐3417/11/7/3116. [Google Scholar]
  33. Dj Nevena, I. , Hippe B., Lilja S., and Haslberger A. G.. 2022. “Precise Nutrition and Functional Foods.” In Advances in Precision Nutrition, Personalization and Healthy Aging, 231–267. Springer. [Google Scholar]
  34. Djuricic, I. , and Calder P. C.. 2021. “Beneficial Outcomes of omega‐6 and omega‐3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021.” Nutrients 13, no. 7: 2421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dumay, J. , and Morançais M.. 2016. “Chapter 9 ‐ Proteins and Pigments.” In Seaweed in Health and Disease Prevention, edited by Fleurence J. and Levine I., 275–318. Academic Press. 10.1016/B978-0-12-802772-1.00009-9. [DOI] [Google Scholar]
  36. Eddaikra, A. , and Eddaikra N.. 2021. “Endogenous Enzymatic Antioxidant Defense and Pathologies.” In Antioxidants‐Benefits, Sources, Mechanisms of Action. IntechOpen. [Google Scholar]
  37. EFSA, E. F. S. A . 2022. “Cannabinoids in Food: Applications and Data Requirements.” https://www.efsa.europa.eu/en/news/cannabinoids‐food‐applications‐and‐data‐requirements.
  38. Elbandy, M. 2022. “Anti‐Inflammatory Effects of Marine Bioactive Compounds and Their Potential as Functional Food Ingredients in the Prevention and Treatment of Neuroinflammatory Disorders.” Molecules 28, no. 1: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Essa, M. M. , Bishir M., Bhat A., et al. 2023. “Functional Foods and Their Impact on Health.” Journal of Food Science and Technology 60, no. 3: 820–834. 10.1007/s13197-021-05193-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Evans, J. , Richards J. R., and Battisti A. S.. 2025. Caffeine. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: John Richards Declares No Relevant Financial Relationships With Ineligible Companies. Disclosure: Amanda Battisti Declares No Relevant Financial Relationships With Ineligible Companies. StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC. [Google Scholar]
  41. Fakhri, S. , Moradi S. Z., Yarmohammadi A., Narimani F., Wallace C. E., and Bishayee A.. 2022. “Modulation of TLR/NF‐κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.” Frontiers in Oncology 12: 834072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Farahmandi, K. , Mohr A. E., and McFarland L. V.. 2022. “Effects of Probiotics on Allergic Rhinitis: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials.” American Journal of Rhinology & Allergy 36, no. 4: 440–450. 10.1177/19458924211073550. [DOI] [PubMed] [Google Scholar]
  43. FDA, U. S . 2024. FDA Regulation of Cannabis and Cannabis‐Derived Products, Including Cannabidiol (CBD). FDA, U. S. [Google Scholar]
  44. Foods, M. H. H. 2025. “Hemp Hearts.” https://manitobaharvest.com.
  45. Frumuzachi, O. , Flanagan A., Rohn S., and Mocan A.. 2025. “The Dichotomy Between Functional and Functionalized Foods – A Critical Characterization of Concepts.” Food Research International 208: 116173. 10.1016/j.foodres.2025.116173. [DOI] [PubMed] [Google Scholar]
  46. Ganguly, P. , Macleod T., Wong C., Harland M., and McGonagle D.. 2023. “Revisiting p38 Mitogen‐Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK‐Activated Protein Kinase Inhibitors (MK2i).” Pharmaceuticals 16, no. 9: 1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Gao, H. , Song R.‐J., Jiang H., Zhang W., and Han S.‐F.. 2022. “Oat Fiber Supplementation Alleviates Intestinal Inflammation and Ameliorates Intestinal Mucosal Barrier via Acting on Gut Microbiota‐Derived Metabolites in LDLR−/− Mice.” Nutrition 95: 111558. [DOI] [PubMed] [Google Scholar]
  48. Gass, M. L. S. , and Khan S.. 2013. “Chapter 77 ‐ Estrogen and Estrogen Analogs for Prevention and Treatment of Osteoporosis.” In Osteoporosis, edited by Marcus R., Feldman D., Dempster D. W., Luckey M., and Cauley J. A., Fourth ed., 1805–1825. Academic Press. 10.1016/B978-0-12-415853-5.00077-7. [DOI] [Google Scholar]
  49. Green, M. , Arora K., and Prakash S.. 2020. “Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.” International Journal of Molecular Sciences 21, no. 8: 2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Grinberga‐Zalite, G. , Zvirbule A., and Hernik J.. 2024. “Fostering a Link Between Creativity and Consumer Acceptance: Essential Factors for Advancing Innovations in Food Industry.” Creativity Studies 17, no. 1: 309–322. [Google Scholar]
  51. Grzelczyk, J. , Szwajgier D., Baranowska‐Wójcik E., et al. 2023. “Effect of Inhibiting Butyrylcholinesterase Activity Using Fractionated Coffee Extracts Digested In Vitro in Gastrointestinal Tract: Docking Simulation and Calorimetric and Studies.” Nutrients 15, no. 10: 2366. https://www.mdpi.com/2072‐6643/15/10/2366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Guimarães, M. R. , Leite F. R., Spolidorio L. C., Kirkwood K. L., and Rossa C. Jr. 2013. “Curcumin Abrogates LPS‐Induced Pro‐Inflammatory Cytokines in RAW 264.7 Macrophages. Evidence for Novel Mechanisms Involving SOCS‐1, ‐3 and p38 MAPK.” Archives of Oral Biology 58, no. 10: 1309–1317. 10.1016/j.archoralbio.2013.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hadi, A. , Pourmasoumi M., Kazemi M., Najafgholizadeh A., and Marx W.. 2022. “Efficacy of Synbiotic Interventions on Blood Pressure: A Systematic Review and Meta‐Analysis of Clinical Trials.” Critical Reviews in Food Science and Nutrition 62, no. 20: 5582–5591. [DOI] [PubMed] [Google Scholar]
  54. Hasanuzzaman, M. , Bhuyan M., Zulfiqar F., et al. 2020. “Reactive Oxygen Species and Antioxidant Defense in Plants under Abiotic Stress: Revisiting the Crucial Role of a Universal Defense Regulator.” Antioxidants (Basel) 9, no. 8. 10.3390/antiox9080681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hasler, C. M. 2002. “Functional Foods: Benefits, Concerns and Challenges—A Position Paper From the American Council on Science and Health.” Journal of Nutrition 132, no. 12: 3772–3781. 10.1093/jn/132.12.3772. [DOI] [PubMed] [Google Scholar]
  56. Heinrich, M. , Mah J., and Amirkia V.. 2021. “Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity‐An Update and Forward Look.” Molecules 26, no. 7. 10.3390/molecules26071836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hilma . 2020. “Hilma Daily Pre + Probiotic + Herbs.” https://www.hilma.co/products/digestive‐essentials?srsltid=AfmBOopxutY7YwqhRxZ8D8BDXTRCKLyyxBDSqUXlp0fZUQ6h5xWhLo97.
  58. Hossain, A. , Yeo J., Dave D., and Shahidi F.. 2022. “Phenolic Compounds and Antioxidant Capacity of Sea Cucumber (Cucumaria frondosa) Processing Discards as Affected by High‐Pressure Processing (HPP).” Antioxidants 11, no. 2: 337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Hou, W. , Liu Z., Zhang Y., Li S., and Liu C.. 2024. “In‐Depth Analysis of the Acetylcholinesterase Inhibitors of Ganoderma Amboinense Based Receptor‐Ligand Affinity Coupled With Complex Chromatography.” Journal of Food Composition and Analysis 125: 105776. 10.1016/j.jfca.2023.105776. [DOI] [Google Scholar]
  60. Huang, J. , Hu Z., Li G., Hu L., Chen J., and Hu Y.. 2022. “Make Your Packaging Colorful and Multifunctional: The Molecular Interaction and Properties Characterization of Natural Colorant‐Based Films and Their Applications in Food Industry.” Trends in Food Science & Technology 124: 259–277. 10.1016/j.tifs.2022.04.028. [DOI] [Google Scholar]
  61. HuelLimited . 2015. –2025. “Huel: Ready‐to‐Drink, On‐the‐Go Complete Meal.” https://huel.com.
  62. IRRI . 2025. “Golden Rice Meets Food Safety Standards in Three Global Leading Regulatory Agencies.” https://www.irri.org/.
  63. ISAAA . 2018. “Golden Rice Gets Approval From US FDA.” https://www.isaaa.org/default.asp.
  64. Islam, M. N. , Rauf A., Fahad F. I., et al. 2022. “Superoxide Dismutase: An Updated Review on Its Health Benefits and Industrial Applications.” Critical Reviews in Food Science and Nutrition 62, no. 26: 7282–7300. [DOI] [PubMed] [Google Scholar]
  65. Jamai, K. , Daoudi N. E., Elrherabi A., and Bnouham M.. 2024. “Medicinal Plants and Natural Products to Treat Obesity Through Inhibiting Pancreatic Lipase: A Review (2020–2022).” Letters in Drug Design & Discovery 21, no. 11: 1936–1955. [Google Scholar]
  66. Jauhiainen, T. , Vapaatalo H., Poussa T., Kyrönpalo S., Rasmussen M., and Korpela R.. 2005. “ Lactobacillus helveticus Fermented Milk Lowers Blood Pressure in Hypertensive Subjects in 24‐h Ambulatory Blood Pressure Measurement.” American Journal of Hypertension 18, no. 12 Pt 1: 1600–1605. 10.1016/j.amjhyper.2005.06.006. [DOI] [PubMed] [Google Scholar]
  67. Jones, P. J. , and Jew S.. 2007. “Functional Food Development: Concept to Reality.” Trends in Food Science & Technology 18, no. 7: 387–390. 10.1016/j.tifs.2007.03.008. [DOI] [Google Scholar]
  68. Kannan, G. , Paul B. M., and Thangaraj P.. 2025. “Stimulation, Regulation, and Inflammaging Interventions of Natural Compounds on Nuclear Factor Kappa B (NF‐kB) Pathway: A Comprehensive Review.” Inflammopharmacology 33, no. 1: 145–162. [DOI] [PubMed] [Google Scholar]
  69. Kato‐Kataoka, A. , Nishida K., Takada M., et al. 2016. “Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress.” Applied and Environmental Microbiology 82, no. 12: 3649–3658. 10.1128/aem.04134-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Kaur, G. , Kaur R., Sodhi G. K., et al. 2024. “Stilbenes: A Journey from Folklore to Pharmaceutical Innovation.” Archives of Microbiology 206, no. 5: 229. 10.1007/s00203-024-03939-z. [DOI] [PubMed] [Google Scholar]
  71. Kavyani, Z. , Musazadeh V., Fathi S., Faghfouri A. H., Dehghan P., and Sarmadi B.. 2022. “Efficacy of the Omega‐3 Fatty Acids Supplementation on Inflammatory Biomarkers: An Umbrella Meta‐Analysis.” International Immunopharmacology 111: 109104. [DOI] [PubMed] [Google Scholar]
  72. kelloggs.co.uk . n.d. “kelloggs.” https://www.kelloggs.co.uk/en_GB/nutrition/adding‐vitamins‐and‐minerals.html#:~:text=%C2%A9%202025%20Kellanova.%20All%20rights%20reserved.
  73. Khalaf, A. T. , Wei Y., Alneamah S. J. A., et al. 2021. “What Is New in the Preventive and Therapeutic Role of Dairy Products as Nutraceuticals and Functional Foods?” BioMed Research International 2021, no. 1: 8823222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Kheto, A. , Adhikary U., Dhua S., et al. 2025. “A Review on Advancements in Emerging Processing of Whey Protein: Enhancing Functional and Nutritional Properties for Functional Food Applications.” Food Safety and Health 3, no. 1: 23–45. [Google Scholar]
  75. Khurana, V. , and Goswami B.. 2022. “Angiotensin Converting Enzyme (ACE).” Clinica Chimica Acta 524: 113–122. [DOI] [PubMed] [Google Scholar]
  76. Koolaji, N. , Shammugasamy B., Schindeler A., Dong Q., Dehghani F., and Valtchev P.. 2020. “Citrus Peel Flavonoids as Potential Cancer Prevention Agents.” Current Developments in Nutrition 4, no. 5: nzaa025. 10.1093/cdn/nzaa025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Kothari, D. , Patel S., and Kim S.‐K.. 2019. “Probiotic Supplements Might Not Be Universally‐Effective and Safe: A Review.” Biomedicine & Pharmacotherapy 111: 537–547. 10.1016/j.biopha.2018.12.104. [DOI] [PubMed] [Google Scholar]
  78. Krüger, M. , van Eeden T., and Beswa D.. 2022. “ Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods—Historical and Developmental Aspects.” Plants 11, no. 23: 3330. https://www.mdpi.com/2223‐7747/11/23/3330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Kumar, D. , Lal M. K., Dutt S., et al. 2022. “Functional Fermented Probiotics, Prebiotics, and Synbiotics from Non‐Dairy Products: A Perspective from Nutraceutical.” Molecular Nutrition & Food Research 66, no. 14: 2101059. [DOI] [PubMed] [Google Scholar]
  80. Lamsar, H. , and Abhilasha A.. 2023. “Chapter Four – Dairy‐Based Functional Food Products.” In Industrial Application of Functional Foods, Ingredients and Nutraceuticals, edited by Anandharamakrishnan C. and Subramanian P., 127–170. Academic Press. [Google Scholar]
  81. Lee, J. , Seto D., and Bielory L.. 2008. “Meta‐Analysis of Clinical Trials of Probiotics for Prevention and Treatment of Pediatric Atopic Dermatitis.” Journal of Allergy and Clinical Immunology 121, no. 1: 116–121. 10.1016/j.jaci.2007.10.043. [DOI] [PubMed] [Google Scholar]
  82. Li, F. , Zeng K., and Ming J.. 2025. “Lowering Glycemic Levels via Gastrointestinal Tract Factors: The Roles of Dietary Fiber, Polyphenols, and Their Combination.” Critical Reviews in Food Science and Nutrition 65, no. 3: 575–611. [DOI] [PubMed] [Google Scholar]
  83. Lim, S. Y. , Steiner J. M., and Cridge H.. 2022. “Lipases: It's Not Just Pancreatic Lipase!” American Journal of Veterinary Research 83, no. 8. 10.2460/ajvr.22.03.0048. [DOI] [PubMed] [Google Scholar]
  84. Liu, J. , He Z., Ma N., and Chen Z.‐Y.. 2020. “Beneficial Effects of Dietary Polyphenols on High‐Fat Diet‐Induced Obesity Linking With Modulation of Gut Microbiota.” Journal of Agricultural and Food Chemistry 68, no. 1: 33–47. 10.1021/acs.jafc.9b06817. [DOI] [PubMed] [Google Scholar]
  85. Lobine, D. , Rengasamy K. R., and Mahomoodally M. F.. 2022. “Functional Foods and Bioactive Ingredients Harnessed From the Ocean: Current Status and Future Perspectives.” Critical Reviews in Food Science and Nutrition 62, no. 21: 5794–5823. [DOI] [PubMed] [Google Scholar]
  86. Lu, W. , Shi Y., Wang R., et al. 2021. “Antioxidant Activity and Healthy Benefits of Natural Pigments in Fruits: A Review.” International Journal of Molecular Sciences 22, no. 9: 4945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Ludwiczuk, A. , Skalicka‐Woźniak K., and Georgiev M.. 2017. “Terpenoids.” In Pharmacognosy: Fundamentals, Applications and Strategies, edited by Badal S. and Delgoda R., 233–266. Academic Press. [Google Scholar]
  88. Ma, Z. F. , Fu C., and Lee Y. Y.. 2025. “The Modulatory Role of Bioactive Compounds in Functional Foods on Inflammation and Metabolic Pathways in Chronic Diseases.” Food 14, no. 5: 821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Mafe, A. N. , Edo G. I., Majeed O. S., et al. 2025. “A Review on Probiotics and Dietary Bioactives: Insights on Metabolic Well‐Being, Gut Microbiota, and Inflammatory Responses.” Food Chemistry Advances 6: 100919. [Google Scholar]
  90. Markowiak, P. , and Śliżewska K.. 2017. “Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.” Nutrients 9, no. 9: 1021. 10.3390/nu9091021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Martirosyan, D. , and Alvarado A.. 2023. “Functional Foods Regulation System: Proposed Regulatory Paradigm by Functional Food Center.” Functional Food Science 3: 275. 10.31989/ffs.v3i11.1265. [DOI] [Google Scholar]
  92. Martirosyan, D. , Lampert T., and Lee M.. 2022. “A Comprehensive Review on the Role of Food Bioactive Compounds in Functional Food Science.” Functional Food Science 2, no. 3: 64–78. [Google Scholar]
  93. Matumoto‐Pintro, P. T. , Murakami A. E., Vital A. C. P., et al. 2017. “Effects of Storage Time and Temperature on Lipid Oxidation of Egg Powders Enriched With Natural Antioxidants.” Food Chemistry 228: 463–468. 10.1016/j.foodchem.2017.02.044. [DOI] [PubMed] [Google Scholar]
  94. McClements, D. , and Xiao H.. 2014. “Excipient Foods: Designing Food Matrices That Improve the Oral Bioavailability of Pharmaceuticals and Nutraceuticals.” Food & Function 5: 1320–1333. 10.1039/c4fo00100a. [DOI] [PubMed] [Google Scholar]
  95. Meat, B. 2024. “New Beyond Burger.” https://www.beyondmeat.com/en‐US/.
  96. Medoro, A. , Scapagnini G., and Davinelli S.. 2024. “Polyphenol Supplementation and Sarcopenia: A Systematic Review and Meta‐Analysis of Clinical Trials.” Journal of Frailty & Aging 13, no. 4: 432–440. 10.14283/jfa.2024.73. [DOI] [PubMed] [Google Scholar]
  97. Mehboob, K. 2025. “Cost‐Benefit Analysis of Preventive Healthcare Programs.” Pakistan Journal of Health Sciences 6, no. 4: 01. 10.54393/pjhs.v6i4.3068. [DOI] [Google Scholar]
  98. Mellentin, J. 2023. “Key Trends in Functional Foods for 2024: Young People in Particular Are Hungry for Health Benefits from Food. As Nutrition’rules’ Change and Consumer Need‐States Evolve, New Business Opportunities Emerge.” Nutraceuticals World 26, no. 9: 36–40. [Google Scholar]
  99. Michaud, T. L. , You W., Wilson K. E., et al. 2017. “Cost Effectiveness and Return on Investment of a Scalable Community Weight Loss Intervention.” Preventive Medicine 105: 295–303. 10.1016/j.ypmed.2017.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Michella, S. , and Slaugh B.. 2000. “Producing and Marketing a Specialty Egg.” Poultry Science 79: 975–976. 10.1093/ps/79.7.975. [DOI] [PubMed] [Google Scholar]
  101. Mihaylova, D. , Dimitrova‐Dimova M., and Popova A.. 2024. “Dietary Phenolic Compounds‐Wellbeing and Perspective Applications.” International Journal of Molecular Sciences 25, no. 9. 10.3390/ijms25094769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Mihociu, T. E. , Cimponeriu D. G., Mustatea G., and Belc N.. 2024. “Bioaccessibility and Stability of Phytochemical Compounds, Essential Features in the Design of Functional Foods: A Review.” Journal of Hygienic Engineering and Design 46, no. 1: 179–191. [Google Scholar]
  103. Mondal, S. , Soumya N. P. P., Mini S., and Sivan S. K.. 2021. “Bioactive Compounds in Functional Food and Their Role as Therapeutics.” Bioactive Compounds in Health and Disease 4, no. 3: 24–39. [Google Scholar]
  104. Mrowicka, M. , Mrowicki J., Kucharska E., and Majsterek I.. 2022. “Lutein and Zeaxanthin and Their Roles in Age‐Related Macular Degeneration‐Neurodegenerative Disease.” Nutrients 14, no. 4. 10.3390/nu14040827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Munteanu, I. G. , and Apetrei C.. 2021. “Analytical Methods Used in Determining Antioxidant Activity: A Review.” International Journal of Molecular Sciences 22, no. 7: 3380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Musich, S. , Wang S., Hawkins K., and Klemes A.. 2016. “The Impact of Personalized Preventive Care on Health Care Quality, Utilization, and Expenditures.” Population Health Management 19, no. 6: 389–397. 10.1089/pop.2015.0171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Naik, B. , Kumar V., Rizwanuddin S., et al. 2024. “Biofortification as a Solution for Addressing Nutrient Deficiencies and Malnutrition.” Heliyon 10, no. 9: e30595. 10.1016/j.heliyon.2024.e30595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Nassar, M. , Jaffery A., Ibrahim B., Baraka B., and Abosheaishaa H.. 2023. “The Multidimensional Benefits of Eicosapentaenoic Acid: From Heart Health to Inflammatory Control.” Egyptian Journal of Internal Medicine 35, no. 1: 81. 10.1186/s43162-023-00265-6. [DOI] [Google Scholar]
  109. Nayak, S. N. , Aravind B., Malavalli S. S., et al. 2021. “Omics Technologies to Enhance Plant Based Functional Foods: An Overview.” Frontiers in Genetics 12: 742095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Nazzaro, C. , Uliano A., Lerro M., and Stanco M.. 2025. “From Claims to Choices: How Health Information Shapes Consumer Decisions in the Functional Food Market.” Food 14, no. 4: 699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Nestlé . 2025. “S‐26® GOLD Promise Stage 4 Formula Milk Powder.” https://www.wyethnutrition.com.sg/.
  112. NIH, N. I. o. H . 2025. “Vitamin A and Carotenoids; Fact Sheet for Health Professionals.” https://ods.od.nih.gov/factsheets/VitaminA‐HealthProfessional/.
  113. oatly.com . n.d. “Oat Drink.” https://www.oatly.com/products/oat‐drink/oat‐drink‐1l.
  114. Optimum Nutrition . 2025. “Gold Standard 100% Whey™.” https://www.optimumnutrition.com/en‐us.
  115. Pandey, K. B. , and Rizvi S. I.. 2009. “Plant Polyphenols as Dietary Antioxidants in Human Health and Disease.” Oxidative Medicine and Cellular Longevity 2, no. 5: 270–278. 10.4161/oxim.2.5.9498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Pannerchelvan, S. , Rios‐Solis L., Wong F. W. F., et al. 2023. “Strategies for Improvement of Gamma‐Aminobutyric Acid (GABA) Biosynthesis via Lactic Acid Bacteria (LAB) Fermentation.” Food & Function 14, no. 9: 3929–3948. [DOI] [PubMed] [Google Scholar]
  117. Paramanick, D. , Singh V. D., and Singh V. K.. 2022. “Neuroprotective Effect of Phytoconstituents via Nanotechnology for Treatment of Alzheimer Diseases.” Journal of Controlled Release 351: 638–655. 10.1016/j.jconrel.2022.09.058. [DOI] [PubMed] [Google Scholar]
  118. Patel, S. S. , Acharya A., Ray R., Agrawal R., Raghuwanshi R., and Jain P.. 2020. “Cellular and Molecular Mechanisms of Curcumin in Prevention and Treatment of Disease.” Critical Reviews in Food Science and Nutrition 60, no. 6: 887–939. [DOI] [PubMed] [Google Scholar]
  119. Peighambardoust, S. H. , Karami Z., Pateiro M., and Lorenzo J. M.. 2021. “A Review on Health‐Promoting, Biological, and Functional Aspects of Bioactive Peptides in Food Applications.” Biomolecules 11, no. 5: 631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Philippines, Y. 2019. “Yakult; Facts.” https://www.yakult.com.ph/facts.
  121. Phull, A.‐R. , Ahmed M., and Park H.‐J.. 2022. “Cordyceps Militaris as a Bio Functional Food Source: Pharmacological Potential, Anti‐Inflammatory Actions and Related Molecular Mechanisms.” Microorganisms 10, no. 2: 405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Poljsak, B. , Šuput D., and Milisav I.. 2013. “Achieving the Balance Between ROS and Antioxidants: When to Use the Synthetic Antioxidants.” Oxidative Medicine and Cellular Longevity 2013: 956792. 10.1155/2013/956792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Pugazhendhi, A. , Alshehri M. A., Kandasamy S., Sarangi P. K., and Sharma A.. 2025. “Deciphering the Importance of Nanoencapsulation to Improve the Availability of Bioactive Molecules in Food Sources to the Human Body.” Food Chemistry 464: 141762. 10.1016/j.foodchem.2024.141762. [DOI] [PubMed] [Google Scholar]
  124. Quest Nutrition Inc . 2024. “Protein Bars.” https://www.questnutrition.com/.
  125. Rackerby, B. , Le H. N. M., Haymowicz A., Dallas D. C., and Park S. H.. 2024. “Potential Prebiotic Properties of Whey Protein and Glycomacropeptide in Gut Microbiome.” Food Science of Animal Resources 44, no. 2: 299–308. 10.5851/kosfa.2024.e12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Rajaram, S. 2014. “Health Benefits of Plant‐Derived α‐Linolenic acid123.” American Journal of Clinical Nutrition 100: 443S–448S. 10.3945/ajcn.113.071514. [DOI] [PubMed] [Google Scholar]
  127. Rezagholizade‐shirvan, A. , Soltani M., Shokri S., Radfar R., Arab M., and Shamloo E.. 2024. “Bioactive Compound Encapsulation: Characteristics, Applications in Food Systems, and Implications for Human Health.” Food Chemistry: X 24: 101953. 10.1016/j.fochx.2024.101953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Rivero‐Pino, F. , and Montserrat‐de la Paz S.. 2024. “The Role of Bioactive Compounds in Immunonutrition.” Nutrients 16, no. 20: 3432. 10.3390/nu16203432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Romero‐Garay, M. G. , Montalvo‐González E., Hernández‐González C., Soto‐Domínguez A., Becerra‐Verdín E. M., and De Lourdes García‐Magaña M.. 2022. “Bioactivity of Peptides Obtained From Poultry By‐Products: A Review.” Food Chemistry: X 13: 100181. 10.1016/j.fochx.2021.100181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Roşian, Ş. H. , Boarescu I., and Boarescu P.‐M.. 2025. “Antioxidant and Anti‐Inflammatory Effects of Bioactive Compounds in Atherosclerosis.” International Journal of Molecular Sciences 26, no. 3: 1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Ruff, K. J. , DeVore D. P., Leu M. D., and Robinson M. A.. 2009. “Eggshell Membrane: A Possible New Natural Therapeutic for Joint and Connective Tissue Disorders. Results From Two Open‐Label Human Clinical Studies.” Clinical Interventions in Aging 4: 235–240. 10.2147/cia.s5797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Sahu, R. , and Rawal R. K.. 2024. “Modulation of the c‐JNK/p38‐MAPK Signaling Pathway: Investigating the Therapeutic Potential of Natural Products in Hypertension.” Phytomedicine Plus 4: 100564. [Google Scholar]
  133. Saleem, H. , Yaqub A., Rafique R., et al. 2024. “Nutritional and Medicinal Plants as Potential Sources of Enzyme Inhibitors Toward the Bioactive Functional Foods: An Updated Review.” Critical Reviews in Food Science and Nutrition 64, no. 27: 9805–9828. [DOI] [PubMed] [Google Scholar]
  134. Shaikh, S. 2022. “Sources and Health Benefits of Functional Food Components.” In Current Topics in Functional Food, edited by Shiomi N. and Savitskaya A.. IntechOpen. [Google Scholar]
  135. Sharma, M. , Vidhya C., Ojha K., et al. 2024. “The Role of Functional Foods and Nutraceuticals in Disease Prevention and Health Promotion.” European Journal of Nutrition & Food Safety 16: 61–83. [Google Scholar]
  136. Sharma, S. H. , Thulasingam S., and Nagarajan S.. 2017. “Terpenoids as Anti‐Colon Cancer Agents – a Comprehensive Review on Its Mechanistic Perspectives.” European Journal of Pharmacology 795: 169–178. 10.1016/j.ejphar.2016.12.008. [DOI] [PubMed] [Google Scholar]
  137. Shen, S. , Gong C., Jin K., Zhou L., Xiao Y., and Ma L.. 2022. “Omega‐3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta‐Analysis of Randomized Controlled Clinical Trials.” Frontiers in Nutrition 9: 809311. 10.3389/fnut.2022.809311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Shishir, M. R. I. , Gowd V., Suo H., et al. 2021. “Advances in Smart Delivery of Food Bioactive Compounds Using Stimuli‐Responsive Carriers: Responsive Mechanism, Contemporary Challenges, and Prospects.” Comprehensive Reviews in Food Science and Food Safety 20, no. 6: 5449–5488. [DOI] [PubMed] [Google Scholar]
  139. Siddiqui, T. , Khan M. U., Sharma V., and Gupta K.. 2024. “Terpenoids in Essential Oils: Chemistry, Classification, and Potential Impact on Human Health and Industry.” Phytomedicine Plus 4, no. 2: 100549. 10.1016/j.phyplu.2024.100549. [DOI] [Google Scholar]
  140. Sørensen, H. M. , Rochfort K. D., Maye S., et al. 2022. “Exopolysaccharides of Lactic Acid Bacteria: Production, Purification and Health Benefits Towards Functional Food.” Nutrients 14, no. 14: 2938. https://www.mdpi.com/2072‐6643/14/14/2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Spano, M. , Di Matteo G., Ingallina C., et al. 2022. “Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation.” Nutrients 14, no. 3: 490. https://www.mdpi.com/2072‐6643/14/3/490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Steele, C. 2022. “Collagen: A Review of Clinical Use and Efficacy.” Nutritional Medicine Journal 1, no. 2: 12–36. [Google Scholar]
  143. Tafese Awulachew, M. T. 2024. “Functional Foods: Functional Ingredients, Sources and Classification, Health Claims, Food Intolerance, and Allergy.” In Functional Food ‐ Upgrading Natural and Synthetic Sources, edited by Novo Barros A., Campos J., Vilela A., and Fernandes R.. IntechOpen. [Google Scholar]
  144. Temple, N. J. 2022. “A Rational Definition for Functional Foods: A Perspective.” Frontiers in Nutrition 9: 957516. 10.3389/fnut.2022.957516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Topolska, K. , Florkiewicz A., and Filipiak‐Florkiewicz A.. 2021. “Functional Food—Consumer Motivations and Expectations.” International Journal of Environmental Research and Public Health 18, no. 10: 5327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Ud Din, S. R. , Saeed S., Khan S. U., Kiani F. A., Alsuhaibani A. M., and Zhong M.. 2023. “Bioactive Compounds (BACs): A Novel Approach to Treat and Prevent Cardiovascular Diseases.” Current Problems in Cardiology 48, no. 7: 101664. 10.1016/j.cpcardiol.2023.101664. [DOI] [PubMed] [Google Scholar]
  147. Ullah, A. , Munir S., Badshah S. L., et al. 2020. “Important Flavonoids and Their Role as a Therapeutic Agent.” Molecules 25, no. 22. 10.3390/molecules25225243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Unilever . 2025. “Women's Multi.” https://www.olly.com/.
  149. Uro‐Chukwu, H. C. , Uro‐Chukwu F. C., and Uro‐Chukwu F. C.. 2025. “Biological Activities and Mechanisms of Actions of Bioactive Compounds (BACS) Identified in Pure and Ternary Blends of Cocoyam, Soya Bean and Bambara Groundnut Flour Using Gas Chromatography‐Mass Spectrometry (GC‐MS) Technique: A Review.” Journal of Drug Delivery & Therapeutics 15, no. 1: 177–186. [Google Scholar]
  150. Vicentini, A. , Liberatore L., and Mastrocola D.. 2016. “Functional Foods: Trends and Development of the Global Market.” Italian Journal of Food Science 28, no. 2: 338–351. 10.14674/1120-1770/ijfs.v211. [DOI] [Google Scholar]
  151. Victoria Obayomi, O. , Folakemi Olaniran A., and Olugbemiga Owa S.. 2024. “Unveiling the Role of Functional Foods With Emphasis on Prebiotics and Probiotics in Human Health: A Review.” Journal of Functional Foods 119: 106337. 10.1016/j.jff.2024.106337. [DOI] [Google Scholar]
  152. Vignesh, A. , Amal T. C., Sarvalingam A., and Vasanth K.. 2024. “A Review on the Influence of Nutraceuticals and Functional Foods on Health.” Food Chemistry Advances 5: 100749. 10.1016/j.focha.2024.100749. [DOI] [Google Scholar]
  153. Vilas‐Boas, A. A. , Pintado M., and Oliveira A. L.. 2021. “Natural Bioactive Compounds From Food Waste: Toxicity and Safety Concerns.” Food 10, no. 7: 1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Vlaicu, P. A. , Panaite T. D., and Turcu R. P.. 2021. “Enriching Laying Hens Eggs by Feeding Diets With Different Fatty Acid Composition and Antioxidants.” Scientific Reports 11, no. 1: 20707. 10.1038/s41598-021-00343-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Vlaicu, P. A. , Untea A. E., Varzaru I., Saracila M., and Oancea A. G.. 2023. “Designing Nutrition for Health—Incorporating Dietary By‐Products Into Poultry Feeds to Create Functional Foods With Insights Into Health Benefits, Risks, Bioactive Compounds, Food Component Functionality and Safety Regulations.” Food 12, no. 21: 4001. https://www.mdpi.com/2304‐8158/12/21/4001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Vyas, K. , Prabaker S., Prabhu D., et al. 2024. “Study of an Inhibitory Effect of Plant Polyphenolic Compounds Against Digestive Enzymes Using Bench‐Working Experimental Evidence Predicted by Molecular Docking and Dynamics.” International Journal of Biological Macromolecules 259: 129222. 10.1016/j.ijbiomac.2024.129222. [DOI] [PubMed] [Google Scholar]
  157. Wang, Q. , Huang H., Yang Y., et al. 2024. “Reinventing Gut Health: Leveraging Dietary Bioactive Compounds for the Prevention and Treatment of Diseases.” Frontiers in Nutrition 11: 1491821. 10.3389/fnut.2024.1491821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Wani, S. A. , Elshikh M. S., Al‐Wahaibi M. S., and Naik H. R.. 2023. Functional Foods: Technological Challenges and Advancement in Health Promotion. CRC Press. [Google Scholar]
  159. WHO . 2023. Biofortification of Crops With Minerals and Vitamins. WHO. [Google Scholar]
  160. Wu, Y. , Liu Y., Jia Y., Zhang H., and Ren F.. 2024. “Formation and Application of Starch–Polyphenol Complexes: Influencing Factors and Rapid Screening Based on Chemometrics.” Food 13, no. 10: 1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Xavier, J. R. , Sanjay B. S., Gupta D., Mehta S., and Chauhan O. P.. 2024. “Bioactive Compounds of Foods: Phytochemicals and Peptides.” Food and Humanity 3: 100354. 10.1016/j.foohum.2024.100354. [DOI] [Google Scholar]
  162. Yasin, M. , Gangan S., and Panchal S. K.. 2025. “Banana Peels: A Genuine Waste or a Wonderful Opportunity?” Applied Sciences 15, no. 6: 3195. https://www.mdpi.com/2076‐3417/15/6/3195. [Google Scholar]
  163. Yasmin, T. , Menon S. N., Pandey A., et al. 2025. “Resveratrol Attenuates Hepatic Oxidative Stress and Preserves Gut Mucosal Integrity in High‐Fat Diet‐Fed Rats by Modulating Antioxidant and Anti‐Inflammatory Pathways.” Scientific Reports 15, no. 1: 25162. 10.1038/s41598-025-08450-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Ylitalo, R. , Lehtinen S., Wuolijoki E., Ylitalo P., and Lehtimäki T.. 2002. “Cholesterol‐Lowering Properties and Safety of Chitosan.” Arzneimittel‐Forschung 52: 1–7. 10.1055/s-0031-1299848. [DOI] [PubMed] [Google Scholar]
  165. Yuan, X. , Zhong M., Huang X., Hussain Z., Ren M., and Xie X.. 2024. “Industrial Production of Functional Foods for Human Health and Sustainability.” Food 13, no. 22: 3546. https://www.mdpi.com/2304‐8158/13/22/3546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Zhang, L. , Wang X., and Si H.. 2022. “Synergistic Anti‐Inflammatory Effects and Mechanisms of the Combination of Resveratrol and Curcumin in Human Vascular Endothelial Cells and Rodent Aorta.” Journal of Nutritional Biochemistry 108: 109083. 10.1016/j.jnutbio.2022.109083. [DOI] [PubMed] [Google Scholar]
  167. Zhang, Y. , Zhou M., Zhou Y., and Guan X.. 2023. “Dietary Components Regulate Chronic Diseases Through Gut Microbiota: A Review.” Journal of the Science of Food and Agriculture 103, no. 14: 6752–6766. [DOI] [PubMed] [Google Scholar]
  168. Zheng, Y. 2022. “Functional Food VS Health Food: The Different Raceways Under the Big Health Industry.” https://www.cirs‐group.com/en/food/functional‐food‐vs‐health‐food‐the‐different‐raceways‐under‐the‐big‐health‐industry.
  169. Zhou, L. , Xiao X., Zhang Q., Zheng J., and Deng M.. 2019. “Deciphering the Anti‐Obesity Benefits of Resveratrol: The ‘Gut Microbiota‐Adipose Tissue’ Axis.” Frontiers in Endocrinology 10: 413. 10.3389/fendo.2019.00413. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data used during the preparation of this manuscript is available within the article.


Articles from Food Science & Nutrition are provided here courtesy of Wiley

RESOURCES